# team decisions — expertise-weighted

## sigma-ui architecture (26.3.28)

design:framework=Streamlit-conditional |by:product-designer |weight:primary
  |ctx: Q2 — Streamlit vs React/Next.js for local-only, clone-and-run, single-developer orchestration UI
  |evidence: XVERIFY[openai:gpt-5.4] partial — "Streamlit correct for status-dashboard-first MVP; React if tension/viz is central product requirement"
  |decision: Streamlit viable for sigma-ui IF tension/convergence visualization stays monitoring-grade (badge+bar+thread) ¬interactive-graph. Fragment-per-agent-card is MANDATORY architectural constraint ¬optional.
  |inversion-condition: if belief-state visualization requires node-edge graph with drag/zoom → React/Next.js

design:gate-ux=3-tier-reversibility-matched |by:product-designer |weight:primary
  |ctx: Q4 — user gate interaction pattern, modal vs inline vs full-page
  |evidence: CI/CD gate precedent (GitHub Environments), Smashing Magazine agentic UX patterns (2026), modal UX best practices
  |decision: TIER-1(irreversible phase transition)=full-page-takeover | TIER-2(round advance)=modal overlay | TIER-3(informational)=inline banner | pre-action: show consequences before confirm button active

design:IA=5-level-hierarchy |by:product-designer |weight:primary
  |ctx: Q2 sub-question — information architecture for status dashboard
  |decision: L1:phase-strip(persistent) | L2:agent-grid(20-cards) | L3:agent-detail(click-expand) | L4:findings-feed(append-only,chronological) | L5:tension-panel(drawer,deliberate-friction)
  |anti-patterns: flat-trace-list, token-metrics-primary, auto-expand-all, live-scroll-while-reading

design:tension-viz=threaded-¬graph |by:product-designer |weight:primary
  |ctx: tension/convergence visualization scope
  |decision: DA-challenge + agent-responses as threaded conversation metaphor ¬node-edge graph at MVP | convergence=per-agent-badge+aggregate-bar | belief-state=confidence-pct+trend-arrow

## biotech-healthcare M&A review (26.3.18)

H1-reconciliation:AI=deal-shaper-¬deal-engine |by:product-strategist(r3-concession)+RCA(r1) |weight:primary
  |ctx: PS revised H1 from CONFIRMED→PARTIALLY CONFIRMED after DA[#1] challenge |RCA outside-view (additive ¬primary) now accepted by PS
  |evidence: patent cliff + rates + $2.1T firepower = 75-80% of M&A volume motivation | AI = 20-25% by 2031, 10% 2025
  |decision: H1 synthesis anchor = "AI is deal shaper ¬deal engine" | AI creates new target categories + reshapes premium structures WITHIN cliff-driven M&A cycle ¬creates independent demand
  |falsification: ≤3 AI-native acq >$1B 2026-2028 + Phase III failures → thesis falsified | AI-biotech correction >40% → premium thesis falsified

173-programs-phase-decomposition:~120-P1/~45-P2/~8-P3 |by:product-strategist(r3) |weight:supporting
  |ctx: DA[#8] challenge — "173" cited by 5 agents without quality decomposition
  |evidence: BiopharmaTrend sample ratio P1-dominant (55%+) | systematic review 2015-2025: 23.1% Phase I | 15-20 pivotal = 9-12% of 173
  |decision: M&A-relevant near-term = 15-20 pivotal programs | AI-molecule-driven M&A peak = 2028-2030 ¬2026 | platform M&A (buy engine) window = 2026-2027

liquid-biopsy-multi-omics=TIER-1-M&A |by:product-strategist(r3) |weight:primary
  |ctx: material omission from R1 sector ranking | Abbott/Exact Sciences, Samsung/GRAIL, Natera/Foresight = active NOW
  |evidence: ~$60B diagnostics M&A 2025 | Abbott/Exact Sciences Q2-2026-close | liquid biopsy market $46.8B by 2030 CAGR 11.52%
  |decision: liquid biopsy + multi-omics AI = TIER-1 alongside drug discovery + medical imaging | not subsumed under diagnostics

deal:AI-premium-bifurcated |by:portfolio-analyst |weight:primary
  |ctx: Recursion+Exscientia merged=$1.8B combined(two leading AI firms) |platform-alone ¬sufficient for premium |Recursion P/S 33-41x vs sector 10-11x when clinical proof present |preclinical platforms 40-70% premium vs approved products 80-120%
  |decision: AI premium REAL for Tier-1(clinical validation) ¬universal |clinical proof = separator

deal:CVR-prevalence-structural |by:portfolio-analyst |weight:primary
  |ctx: avg 37% of total deal size in larger transactions |milestone payment +255% Q4 2025 vs Q3 |Pfizer/Metsera $4.9B upfront+$2.3B CVRs |Lilly/Adverum $3.56+$8.91 CVR
  |decision: CVR structures structurally embedded in pharma M&A ¬tactical exception |signals sustained buyer risk-aversion to binary clinical outcomes 2026-2031

deal:China-licensing-primary-structure |by:portfolio-analyst |weight:primary
  |ctx: 32% of worldwide out-licensing value H1 2025(up from 21% 2023-24) |$57.3B deal value at only $3.9B upfront(leverage ~15x) |AZ/CSPC $5.3B total $110M upfront
  |decision: licensing ¬full acquisition = Western pharma preferred structure for China-sourced assets |geopolitical+IP risk drives structure choice ¬clinical quality

deal:FTC-preclinical-overlap-risk-confirmed |by:portfolio-analyst |weight:primary
  |ctx: Edwards/JC Medical+JenaValve blocked Aug 2025 on TAVR-AR clinical trial overlap(¬commercial overlap)
  |decision: FTC preclinical overlap = material deal risk ¬theoretical |AI platform acquisitions face LESS scrutiny than therapeutic pipeline overlaps |favors platform M&A strategy

deal:biotech-MA-cycle-late-expansion |by:portfolio-analyst |weight:primary
  |ctx: 2025 M&A $228-240B announced |deal count 50(highest since 2021) |structural gap $370B by 2032 |$2.1T firepower vs <65% coverage ratio
  |decision: current cycle late-expansion ¬peak |2015-2016 analog(structural LOE pressure) ¬2021 froth |multi-year durability justified ¬cyclical fade

deal:public-biotech-arbitrage-open |by:portfolio-analyst |weight:primary
  |ctx: healthcare sector at 30% discount to broader market |~50% of public US biotech trade below cash NAV |XBI recovery ¬yet erased discount
  |decision: public-to-private arbitrage window STILL OPEN entering 2026 |watch signal: XBI <15% discount to market P/E = window closing

deal:AI-premium-compression-already-occurring |by:portfolio-analyst(r3) |weight:primary
  |ctx: DA[#2] challenge — AI premium not modeled for compression risk
  |evidence: Recursion RXRX $3.39 (Mar 16 2026) down from ATH $41.33 (Jul 2021), -31% prior 12mo |BenevolentAI delisted Mar 2025 |genomics bubble 2000-2001: -70-80% compression ¬eliminated M&A, delayed+repriced it |CRISPR collapse 2021-2022: -50-80%, forced licensing-before-acquisition structures
  |decision: 40% premium compression restructures M&A (volume holds, deal values fall 25-40%) ¬kills it | 60% extreme collapses AI-only platforms to acqui-hire | M&A VOLUME thesis ROBUST (patent cliff drives regardless) | AI PREMIUM thesis FRAGILE (requires Phase 3 clinical proof) — synthesis must separate these two claims
  |leading-indicators: Insilico rentosertib Phase 3 readout (!CRITICAL), Recursion cash runway sub-18mo, Dalio euphoria composite >90%

deal:post-acquisition-integration-risk-AI-specific |by:portfolio-analyst(r3) |weight:primary
  |ctx: DA[#4] challenge — integration risk absent from all R1 analyses
  |evidence: 40-60% general pharma M&A integration failure base rate | AI-specific +10-15pp = 50-70% | Watson Health: $5B+ acquisitions → $1B (2022), 80% value destruction | root causes: Blue Washing (forced tech stack migration), talent flight, culture clash | McKinsey: outperformers 3.4-8.2x better on SAME assets — execution variance as large as asset quality
  |decision: archetype ranking REVISED (integration-adjusted): RANK-1=late-stage-pipeline, RANK-2=platform+clinical-validation(20-25% expected-value haircut), RANK-3=China-licensing(avoids integration), RANK-4=PE-take-private, RANK-5=AI-only-platform(double-penalized) | recommend option-to-acquire ¬outright acquisition for AI-native platforms

deal:BIOSECURE-scope-distinction-critical |by:portfolio-analyst(r3) |weight:primary
  |ctx: DA[#6] challenge — China licensing sustainability questioned
  |evidence: BIOSECURE targets CDMO/CRO service providers (WuXi AppTec, BGI etc.) ¬innovative drug developers | PA-F9 $57.3B = innovative drug licensing ¬CDMO contracts | cross-border deals 42/$1.1B (2022) → 93/$5.6B (2025) = 400% upfront value increase | 2026 pace holding steady, on track for new record
  |decision: near-term (2026-2027) China licensing channel OPEN and accelerating | 3-horizon: OPEN→STRESSED(2027-2029)→AT-RISK(2029-2031) | P(>50% contraction by 2031)=25-35% | RANK-3 temporalized: maintained 2026-2027, degraded to RANK-4 equivalent 2028-2030 | all new licensing structures require manufacturing-rights clauses + US FDA filing provisions + IP audit rights

## sigma-mem v0.1 review (26.3.7)

arch:weighted-state-detection |by:tech-architect |weight:primary
  |ctx: replaced first-match keywords with scoring system, all reviewers confirmed improvement
  |alt: ML classifier (ruled out — overkill for current scale)

arch:path-validation-via-resolve |by:tech-architect |weight:primary
  |ctx: _validate_path uses resolve()+is_relative_to(), product-strategist confirmed as shipping prerequisite

product:alpha-quality-reached |by:product-strategist |weight:primary
  |ctx: 0→32 tests, security hardened, tech-architect confirmed fixes correct
  |blockers: README, LICENSE, git init, hateoas-agent publish for PyPI

ux:dual-user-tension-acknowledged |by:ux-researcher |weight:primary
  |ctx: AI-optimized notation vs human maintainer, tech-architect noted rosetta.md helps, product-strategist noted this is moat+barrier
  |status: accepted tradeoff, not resolved

## hateoas-agent v0.1.0 release review (26.3.7)

product:ship-ready |by:product-strategist |weight:primary
  |ctx: README exceptional, packaging complete, only trivial blockers (LICENSE author, repo cleanup)
  |ctx: tech-architect confirmed arch(A-) security(A), ux-researcher confirmed DX(B+)

arch:_state-convention-is-footgun |by:tech-architect |weight:primary
  |ctx: ux-researcher independently flagged silent failure when _state omitted, both recommend explicit return type or warning
  |decision: document prominently for v0.1, consider ActionResult wrapper for v0.2

arch:anthropic-should-be-optional-dep |by:tech-architect |weight:primary
  |ctx: product-strategist noted anthropic-only limits audience, model-agnostic Runner is #1 growth lever
  |decision: make optional before publish if feasible, otherwise v0.2

ux:add-startup-validation |by:ux-researcher |weight:primary
  |ctx: tech-architect confirmed missing handlers only caught at runtime, ux-researcher identified as highest-impact DX improvement
  |decision: add StateMachine.validate() called by Runner.__init__

product:readme-keep-as-is |by:product-strategist |weight:primary
  |ctx: all three reviewers praised README quality, minor fixes only (quick-start runnability, example count)

## hateoas-agent v0.1.0 delta review (26.3.7)

review-5-resolved |by:all-three |weight:consensus
  |ctx: anthropic-optional(✓), validate-at-init(✓), quick-start-runnable(✓), LICENSE-author(✓), __version__(✓), runner-exception-safe(✓)
  |grades: arch(A-) api(A-) security(A) release(B+) DX(A-)

product:ship-go |by:product-strategist |weight:primary
  |ctx: all substantive blockers resolved, 3 mechanical prereqs remain (git-init, rebuild-dist, update-examples-in-README)

arch:_state-docs-still-needed |by:all-three |weight:consensus
  |ctx: team decision from review-4 to "document prominently" was not executed, all three re-flagged independently

ux:Resource-validate-parity |by:ux-researcher,tech-architect |weight:primary
  |ctx: StateMachine.validate() exists but Resource class has none, Runner silently skips via hasattr

## team infrastructure v2 (26.3.7)

arch:self-sufficient-agents |by:user+lead |weight:directive
  |ctx: agents read own files at boot, no memory injection by lead
  |replaces: lead-injects-memory-into-prompt

arch:markdown-inboxes |by:user+lead |weight:directive
  |ctx: replaced JSON inboxes with markdown/ΣComm format, summarize-and-clear pattern
  |replaces: JSON inbox files (unused)

arch:shared-workspace |by:user+lead |weight:directive
  |ctx: shared/workspace.md for current task, agents write to own section, declare convergence
  |new: workspace.md, agent-declared convergence in workspace

arch:user-can-address-agents |by:user+lead |weight:directive
  |ctx: @agent-name routes user message to agent inbox in plain language, agent gets shared context
challenge:ceasefire-probability-underpriced |team 22-28% vs Polymarket 52%(Apr 30), 67%(Jun 30) |recommend revise to 35-45% |by:devils-advocate |weight:primary
  |ctx: prediction markets, Trump rhetoric("very complete"), Oman backchannel, economic forcing(NFP -92K, GDPNow crash), Iran CIA outreach |bias-detection is devils-advocate primary domain
challenge:portfolio-needs-ceasefire-beneficiary-bucket |current portfolio=100% war-thesis, 0% peace-thesis despite 52% Polymarket ceasefire by Apr |recommend barbell: reduce energy 15→10%, defense 12→8%, add ceasefire bucket 8-10%(airlines,XLY,tech,TLT) |by:devils-advocate |weight:primary
  |ctx: crowding analysis(XLE $1.81B weekly inflows, ITA $16B AUM), max drawdown -8 to -12% on ceasefire, prediction markets, 3/10 Brent $119→$84 in 48hrs |bias-detection+crowding-risk are devils-advocate primary domain

## round-3 debate decisions (energy-market-analyst)

energy:price-range-revised |$90-150→$85-120 tradeable range |$80-85 conditional floor(with SPR) |$90+ without SPR while Hormuz closed |post-conflict $55-65(below pre-war) |by:energy-market-analyst |weight:primary
  |ctx: DA challenge #1(floor anchoring)+#4(demand gradient)+#6(structural surplus). Floor softened by SPR(300-400M over 60-90d=$5-8 off)+demand erosion at $85-90+structural surplus reassertion post-conflict. Bypass math(4-6M of 20M) still valid but ¬sole floor determinant

energy:crowding-risk-acknowledged |XLE $1.81B weekly inflows=crowding signal |XLE ETF conviction HIGH→MODERATE |recommend individual E&P(FANG/EOG)>XLE for lower crowding |by:energy-market-analyst |weight:primary
  |ctx: DA challenge #2. Full concession. 2 rounds, zero positioning analysis=genuine blind spot. BofA+Goldman+JPM same trade=consensus peak. ETF passive flows=mechanical unwind risk

## round-3 debate decisions (sanctions-trade-analyst)

sanctions:enforcement-framing-corrected |2% prosecution rate→13-18% behavioral effectiveness |leakage revised 1.0-1.4M bpd(from 1.2-1.6M) declining |by:sanctions-trade-analyst |weight:primary
  |ctx: DA challenge #3. Full concession. Own data(exports 1.38→1.13-1.20M) proved behavioral reduction. Prosecution rate was lazy metric understating enforcement effectiveness. OFAC bank sanctions could halve leakage to 0.6-0.8M

sanctions:price-floor-temporalized |$90 valid 1-3mo, softens $80-85 by month 4-6 |convergent with energy-market-analyst $80-85 conditional range |by:sanctions-trade-analyst+energy-market-analyst |weight:primary
  |ctx: DA challenge #2(bypass dynamic). Static bypass analysis was fair criticism. Dynamic capacity additions(Saudi Petroline→7M)+demand gradient erode floor over time. BUT Iraq/Kuwait zero bypass=5M+ permanently stranded. Two domain experts independently converged on same revised number

sanctions:tanker-sizing-reduced |3%→2%, NAT removed(Sinokor concentration), covered calls mandatory |FRO(1%)+DHT(1%) |tankers=second-order peace trade(6mo lag) ¬immediate hedge |by:sanctions-trade-analyst |weight:primary
  |ctx: DA challenge #1(retrospective). +60% YTD=retrospective validation ¬prospective edge. Nov $118k→Jan $40k(-66% 6wk)=mean-reversion violence. 40-60% drawdown risk on ceasefire. NOTE: portfolio-analyst keeps 3%(defended separately)→divergence on sizing, alignment on thesis
  |divergence: portfolio-analyst maintains 3%(income at $481K/day, de minimis allocation) |sanctions-trade-analyst recommends 2%(prospective risk/reward degraded)

sanctions:removal-speed-split |existing capacity 3-4mo to market(mine clearance binding), new capacity 9-12mo |¬blanket 6mo |by:sanctions-trade-analyst |weight:primary
  |ctx: DA challenge #4. Iran near existing max(~3.1-3.2M)→incremental from existing=only +100-200k. Market-moving supply=3.2→3.8M ramp(6mo). But mine clearance 8-12wk is BINDING constraint on all supply regardless of sanctions status

energy:demand-destruction-gradient |marginal at $85-90, significant $100-110, recession $120+ |replaces: $120 cliff model |by:energy-market-analyst |weight:primary
  |ctx: DA challenge #4. Full concession. Own r2 insight buried("$100-110 in rate-constrained environment"). Gas $3.54+NFP -92K+discretionary -5.3%=demand already eroding at $91. FFR 3.50-3.75% no stimulus offset

energy:sizing-reduced |15%→10-12% energy allocation recommended |by:energy-market-analyst |weight:primary
  |ctx: crowding+narrower range($85-120 vs $90-150)+demand gradient=smaller optimal energy position. Aligns with DA recommendation(15→10%). Portfolio-analyst v4 already adjusted(15→11%)

energy:BNO-window-tightened |1-3mo→2-6wk tactical |exit triggers: backwardation<$5, convoy begins, ceasefire signals |by:energy-market-analyst |weight:primary
  |ctx: DA challenge #5. Peak backwardation=peak disruption expectations. Physical shortage backwardation persists longer(1990: 4mo) but entry after record=diminished risk/reward

## round-3 debate decisions (geopolitical-strategist)

geopolitical:ceasefire-probability-revised |22-28%→30-38% combined |by:geopolitical-strategist |weight:primary
  |ctx: DA challenge #1. Compromise. Over-weighted Iran stated position("no negotiation") vs revealed behavior(CIA outreach). Historical 3/3 states under existential pressure negotiate. Macro forcing(NFP -92K,gas $3.54)=daily political cost. DEFEND ¬Polymarket 52%(different time horizon 51d vs 30d, different definition bombing-stops vs Hormuz-reopening, Mojtaba consolidation=4-8wk minimum). Split: (a)15-18%+(b)15-20%=30-38%

geopolitical:defense-thesis-downgraded |"scenario-agnostic highest conviction"→"overvalued at current, wait pullback" |by:geopolitical-strategist |weight:primary
  |ctx: DA challenge #2. Full concession—category error. Analyzed demand(JIT→JIC) ¬valuations(LMT $664 vs PT $596=10% overvalued, 27x PE). 3/10 empirical: LMT -4%, NOC -5% on peace signals while S&P +1.5%=defense IS war premium ¬agnostic. $839B budget ALREADY PRICED. Ceasefire drawdown 12-18%. Entry: LMT <$550, NOC <$600

geopolitical:proxy-restraint-time-bounded |static assessment→decay curve: M1 85%, M2 60-65%, M3+ 40-45% |by:geopolitical-strategist |weight:primary
  |ctx: DA challenge #3. Defend with refinement. 67 attacks=IRGC-coordinated retaliation ¬sustained campaign(rate DECLINED Day 3→11). Houthi restraint=rational(governance+legitimacy). Hezbollah=structurally degraded. BUT static assessment was fair criticism→time-bounded decay. Supports (c)→(d) transition at month 2-3

geopolitical:sanctions-framing-revised |"incoherent"→"policy optionality" |by:geopolitical-strategist |weight:primary
  |ctx: DA challenge #4. Compromise. "Incoherent" was normative ¬analytical. Trump DOES contradictory things=demonstrated(Venezuela,India waiver). Physical impact limited: non-Iran relief ~500-800K bpd vs 15M stranded=3-5% of shortfall. Added sub-variant to (c): sustained+non-Iran relief+rhetorical pressure→oil $80-95. Rhetoric=tradeable vol factor WITHIN scenarios

geopolitical:Hormuz-5-phase-timeline |replaces binary ceasefire→reopening model |by:geopolitical-strategist |weight:primary
  |ctx: DA challenge #5. Compromise. Defend 8-12wk mine clearance(sourced USN MCM ops). Concede 3 additions: re-mining risk(IRGC 80-90% small boat capability), insurance normalization 6-12mo beyond physical, bombing cessation≠Hormuz reopening. 5 phases: bombing stops→safe corridor +2-4wk→30-50% throughput +4-8wk→full physical +8-12wk→insurance +6-12mo→full restoration +12-18mo. Extends tanker window, delays energy exit

## round-3 debate decisions (portfolio-analyst — v4 final portfolio)

portfolio:energy-reduced-crowding |15→11% |XLE 6→4%(crowding), E&P(FANG/EOG) 4% maintained, OXY 2%, BNO 1% tactical |by:portfolio-analyst+energy-market-analyst+devils-advocate |weight:primary
  |ctx: DA identified $1.81B XLE weekly inflows=consensus trade, BofA+Goldman+JPM same recommendation. Energy-market-analyst fully conceded crowding blind spot. Individual E&P names less crowded than ETF passive flows. Tradeable range narrowed $85-120(from $90-150)

portfolio:defense-reduced-valuations |12→7% |ITA 4%,LMT 1.5%,RTX 1.5% |by:portfolio-analyst+geopolitical-strategist+devils-advocate |weight:primary
  |ctx: DA identified LMT 27x PE(33% above 10yr avg), consensus HOLD, avg PT $596 vs $664=10% downside. Geopolitical-strategist fully conceded category error(analyzed demand ¬valuations). 3/10 empirical: LMT -4%,NOC -5% on peace signals. Thesis(JIT→JIC) maintained but PRICED IN at current. Entry levels: LMT <$550, NOC <$600

portfolio:ceasefire-bucket-added |0→7% |TLT 3%,airlines/XLY 2%,tech-rebound 2% |by:portfolio-analyst+devils-advocate+macro-rates-analyst |weight:primary
  |ctx: DA's strongest recommendation—portfolio had 100% war thesis, 0% peace thesis despite 35-40% ceasefire probability. Macro-analyst confirmed TLT 3-5% as ceasefire beneficiary(bonds rally on peace). Prediction markets(Polymarket 52% Apr 30) support higher ceasefire weighting. Barbell structure: war+peace positions

portfolio:managed-futures-reduced |5→3% |DBMF 2%,KMLM 1% |by:portfolio-analyst+macro-rates-analyst+devils-advocate |weight:primary
  |ctx: DA identified whipsaw risk($30 round-trips/48hrs), DBMF -8.9%(2023) in non-trending. Macro-analyst independently revised 5→3%, confirmed options>trend-following in binary environments

portfolio:ceasefire-probability-revised |22-28%→35-40% for portfolio planning |by:portfolio-analyst+geopolitical-strategist+devils-advocate |weight:consensus
  |ctx: DA correctly identified team underpricing(vs Polymarket 52% Apr 30). Geopolitical-strategist revised 30-38%(macro forcing+Iran revealed behavior). Time horizon explains gap(30d vs 51d). Team convergent at 35-40%

portfolio:tanker-divergence-logged |portfolio-analyst 3% vs sanctions-trade-analyst 2% |FRO 1.5%+DHT 1.5%(NAT removed) |by:portfolio-analyst(3%)+sanctions-trade-analyst(2%) |weight:split
  |ctx: both agree thesis valid(mine clearance→ton-mile persists, Iranian ramp needs VLCC). Disagree on prospective risk/reward at +60%. Portfolio-analyst: 3% de minimis, income at $481K/day, 5-phase extends window. Sanctions-trade: Sinokor concentration, -66% mean-reversion evidence. NAT removed per Sinokor concern—convergent. Covered calls mandatory—convergent

portfolio:gold-maintained-with-protection |10% maintained |GLD 7%,GDX 3%,$4,800 stop,GLD puts added |by:portfolio-analyst+macro-rates-analyst |weight:primary
  |ctx: DA challenged(WGC 5-20% crash risk, late entry at +22% YTD). Macro-analyst defended(structural: CB 755t buying, real rates falling, reversal requires Fed hiking into recession). Portfolio-analyst: correlation stressed(IMF+Oxford Econ)=gold THE hedge. Added $4,800 stop(-11%)+put protection as compromise

portfolio:v4-max-drawdown-improved |-8/-12%→-4/-7% on ceasefire scenario |by:portfolio-analyst |weight:primary
  |ctx: war positions reduced ~12pp(energy -4, defense -5, managed futures -2). Peace positions added 7%(ceasefire bucket). SPY puts provide equity downside protection. Cash 13% provides rebalancing dry powder

## round-3 final assessment decisions (devils-advocate)

bias:confirmation-bias-partially-corrected |analog selection now explicitly justified(physical removal vs threats), tanker "win-win" framing persists but at de minimis allocation |by:devils-advocate |weight:primary
  |ctx: energy-market-analyst's base rate reframe was analytically correct—DA used wrong denominator. Team analog selection defensible once justified. Presentation was issue ¬substance

bias:anchoring-corrected |$90 floor→$80-85 conditional, $120 cliff→$85-90/$100-110/$120+ gradient |by:devils-advocate |weight:primary
  |ctx: two domain experts(energy+sanctions) independently converged $80-85. Two-point anchoring replaced with ranges. Most analytically impactful correction

bias:herding-significantly-corrected |5-0 consensus→genuine disagreements+ceasefire bucket+sizing reductions |by:devils-advocate |weight:primary
  |ctx: crowding acknowledged, defense 12→7%, energy 15→11%, ceasefire 22-28%→35-40%, ceasefire bucket 0→7%. 100% war/0% peace→barbelled. !caution: over-correction risk—war-thesis positions remain fundamentally sound(Hormuz IS closed)

## biotech-healthcare-MA-AI-2026-2031 r1 ANALYZE (26.3.18)

regulatory:bifurcated-MA-catalyst |by:regulatory-analyst |weight:primary
  |decision: regulatory-regime=ACCELERANT-for-large-pharma,CHILLING-for-sub-$500M-acquirers
  |ctx: FDA-PCCP-framework(Dec-2024-final,Jan-2025-draft)+EMA-qualification-opinions+biosimilar-acceleration=catalysts-for-large-compliant-players | EU-dual-compliance($8-15M)+notified-body-bottleneck(18-24mo)+US-state-fragmentation=barriers-for-smaller-acquirers | net-effect-is-not-uniform

regulatory:FDA-cleared-SaMD-PCCP-as-MA-moat |by:regulatory-analyst |weight:primary
  |decision: FDA-cleared-AI-SaMD-with-PCCP-in-hand=defensible-acquisition-asset|regulatory-approval-¬replicable-organically-in-reasonable-timeframe|acquirers-paying-premium-for-pre-cleared-platforms
  |ctx: 295-AI-devices-cleared-2025,PCCP-eliminates-future-510k-for-planned-modifications,SaMD-market-$3.81B→$19.58B-2030 | supports-H1(actionable-MA-opportunities) | supports-H4-partial(regulatory-moat=acquisition-imperative)

regulatory:IRA-restructures-deal-mix-toward-biologics |by:regulatory-analyst |weight:primary
  |decision: IRA-pill-penalty(small-mol-9yr-vs-biologic-13yr)+small-mol-funding-DOWN-70%=structural-shift-of-MA-toward-biologics,gene-therapy,ADCs,RNA
  |ctx: 10-drugs-negotiated-prices-live-Jan-2026|post-IRA-large-pharma-RD+MA-INCREASED|biologics-exclusivity-advantage-structural|small-biotech-exclusion-through-2028-protects-pipeline-targets

regulatory:biosimilar-wave-non-AI-MA-catalyst |by:regulatory-analyst |weight:primary
  |decision: biosimilar-approval-acceleration(EMA-44-2025-record,FDA-streamlining-Oct-2025)+patent-cliff-wave(Stelara,Eylea,Prolia)=non-AI-driven-MA-urgency-for-reference-biologic-IP-defense
  |ctx: BPCIA-patent-dance-unchanged-despite-regulatory-streamlining|reference-biologic-IP-acquisition=defensive-MA-strategy|timing:2025-2028-peak-cliff-window

regulatory:federated-learning-gradient-definition-gap |by:regulatory-analyst |weight:primary
  |decision: regulatory-gap-on-whether-model-gradient-sharing=data-sharing-under-GDPR-HIPAA-is-¬resolved|resolution-expected-2026-2027|companies-building-federated-architectures-NOW-face-retroactive-compliance-risk
  |ctx: EDPB-Dec-2024-legitimate-interest-opinion+Digital-Omnibus-GDPR-amendments=partial-signal|cross-border-federated-learning-still-conflicting-consent-standards

assessment:debate-quality |team A-, all 5 engaged honestly, 3 defenses beat DA on merit(base-rate,ceasefire-def,gold) |by:devils-advocate |weight:primary
  |ctx: 6/10 challenges held, 3/10 fell, 1/10 partial. Healthy ratio. Energy+sanctions admitted measuring wrong things(positioning,prosecution rate)→rare analytical maturity

assessment:v4-materially-improved |max drawdown -8/-12%→-4/-7%, ceasefire 0→7%, war-thesis -9pp |by:devils-advocate |weight:primary
  |ctx: DA's 3 strongest contributions: (1) crowding analysis(blind spot), (2) ceasefire bucket(0% peace positions→7%), (3) defense valuations(demand without price=incomplete)

process:crowding-analysis-mandatory-round-1 |positioning/flow analysis standard from r1 in future reviews |by:devils-advocate |weight:directive
  |ctx: zero positioning analysis across 2 rounds of 5-agent work. $1.81B XLE inflows detected only by DA in r3. Should be standard analytical check

process:prediction-market-calibration-early |reference prediction markets in r1 for probability calibration |by:devils-advocate |weight:advisory
  |ctx: team ceasefire 2-3x below Polymarket for 2 rounds. Structural reasons for gap identified post-debate but initial calibration was absent

process:devils-advocate-from-round-2 |stress testing from r2 ¬r3 |by:devils-advocate |weight:advisory
  |ctx: all 3 biases detectable by end of r1. Earlier intervention=more debate rounds=stronger output

## loan admin agent r4 second challenge (26.3.11)

assessment:r4-SYNTHESIZE-recommendation |proceed-to-r5-synthesis,¬additional-agent-response-round |by:devils-advocate |weight:primary
  |ctx: 7 challenges(3H+3M+1L) issued against r3 deepening findings. No challenge invalidates core thesis(loan-admin-agent-for-PC=viable-market). Key risks: 46%-gross-margin=fundraising-challenge(SaaS-benchmark=70-85%), competitive-response-may-be-12mo-not-24mo(AD-Vega+domusAI-in-production), compliance-native=sound-engineering-but-¬external-differentiator(clients-buy-service-¬architecture). Challenges=refinement-caveats-for-synthesis ¬fundamental-objections requiring-agent-response. Both agents maintained A- grade through r3.

assessment:convergence-trajectory-acceptable |r1(HIGH-herd)→r2(DECREASED)→r3(SLIGHTLY-INCREASED)→overall-acceptable |by:devils-advocate |weight:primary
  |ctx: r3 resolved ALL 3 disagreements in 1 round(suspicious speed) and created NEW consensus(compliance-native-as-differentiator). Pattern: team replaces one consensus with another under DA pressure. However, underlying work was substantive(competitive modeling,unit economics,build sequence). Herding=YELLOW(monitor) ¬RED(alarm).

challenge:gross-margin-46%=fundraising-risk |must-model-explicit-path-to-70%+gross-margin-with-AI-automation-milestones |by:devils-advocate |weight:primary
  |ctx: SaaS-investors-require-70-85%-gross-margin(softwareequity,drivetrain,SaaStr). 46%=managed-services-multiple(3-5x-revenue)→Series-B-at-month-24-with-$1-2M-ARR=challenged. Path-to-70%-depends-on-AI-automation-reducing-ops-headcount(40%+stall-after-pilots=base-rate-risk).

challenge:compliance-native-overweight-as-differentiator |reframe-as-internal-efficiency(lower-tech-debt)→¬external-competitive-advantage |by:devils-advocate |weight:advisory
  |ctx: "compliance-by-design"=emerging-best-practice-across-ALL-fintech(¬unique-to-loan-admin). Incumbents(AD,GLAS,Wilmington)=compliance-proven-over-10yr-with-examiners. Clients-select-agents-on-track-record+coverage+relationships+speed→¬architecture-patterns. 0→unanimous-in-1-round=herding-signal.
market-entry:mid-market-PC-via-greenfield-BDC-launches |pipeline:40%-greenfield+30%-successor+30%-sponsor-mandate |segment:BDC+direct-lending(fastest-growing,highest-pain,least-served) |geographic:US-first |by:product-strategist |weight:primary
  |ctx: r1 research: mid-market-PC=consensus-entry-point(all-startups-target). Differentiation-via-greenfield-emphasis(40%-of-pipeline)+charter-requirement. BDC-nontraded=$200B-from-zero-since-2021=structural-greenfield-supply. Addressable=$150-300M. GP-selection:service(72%)+relationships(69%)>technology(21%)
moat-architecture:charter+distribution-primary,technology-secondary |¬data-flywheel-at-zero-AUA(anti-pattern) |durable:(1)trust-charter(18-24mo→permanent-via-relationships),(2)law-firm-referral-network(2-3yr-build),(3)PE-sponsor-relationships,(4)operational-track-record |temporary:AI-native(12-18mo),compliance-by-design(¬external-differentiator-per-DA-r4),speed-to-market |by:product-strategist |weight:primary
  |ctx: r1 research: promoted-pattern distribution>technology-for-finserv-moat applied. GP-selection-criteria:tech=21%-weight confirms. DA-r4-prior:compliance-native=overweighted. Data-flywheel=anti-pattern-at-zero-scale. Charter+relationships=only-durable-moats-validated-by-GLAS(40%-organic-via-law-firm-referrals)+SRS(88%-PE-channel)
alternatives:BUILD-primary(charter+tech+ops,$25-40M-to-breakeven,18-24mo-to-first-facility) |ACQUIRE-Hypercore-DEFER(evaluate-month-12,$40-80M-est) |WHITE-LABEL-REJECT(no-IP-moat) |NULL-kept-as-benchmark(EV-positive-but-high-variance) |by:product-strategist |weight:primary
  |ctx: r1 research: alternatives-analysis-essential-from-r1(promoted-pattern). BUILD=only-path-to-charter+technology-integration-moat. Hypercore-acquisition=$40-80M(Insight-backing-inflates)-deferred-not-rejected. White-label=insufficient-differentiation. Null-hypothesis:relationship-market+$25-40M-commitment=high-bar-to-clear
regulatory:effective-window-2-8mo |gross-18-24mo-minus-regulatory-14-20mo(charter+SOC2+pipeline)=2-8mo-effective |replaces-prior-6-12mo-estimate |competitive-acceleration-in-Q1-2026(GLAS-Oakley+Hypercore-Series-A+S&P-DataXchange) |by:regulatory-licensing-specialist |weight:primary
  |ctx: r1-v2 research. Prior estimate(6-12mo) revised down based on: (1)competitive-acceleration(3-funded-moves-in-Q1-2026), (2)regulatory-setup-timeline-unchanged(14-20mo), (3)gross-window-compression(18-24mo→18-24mo-confirmed-but-may-compress-further). Crypto.com-5mo-OCC validates-charter-speed but ¬changes-total-regulatory-stack-time. PS-F8-window-aligns-at-gross-level.
regulatory:MTMA-31-states-99%-validates-trust-charter-payment-path |charter-eliminates-MTL-requirement-across-99%-of-money-transmission-activity |$1-2M-MTL-cost-avoided |by:regulatory-licensing-specialist |weight:primary
  |ctx: r1-v2 research. CSBS-official-data-Feb2026: 31-states-enacted-MTMA, collectively-99%-of-reported-money-transmission-activity. Trust-company=exempt-from-money-transmitter-requirements. Charter-cost($1.25M-capital)→$0-incremental-for-payment-processing vs MTL($50-100K/state×50=$1-2M+$500K/yr-ongoing). Multi-solving-instrument-principle-confirmed.
ops-tech:waterfall-engine=core-product-decision |dual-mode(BSL+PC)required→BSL-PC-convergence-creating-demand |no-incumbent-spans-both |build-as-custom-DSL/rules-engine+version-control+audit |HIGH-complexity-justified(existential-for-credibility) |by:loan-ops-tech-specialist |weight:primary
  |ctx: r1 research. BSL standardized(OC/IC,sequential tranche). PC bespoke(unitranche,PIK,delayed-draw,custom addbacks). PIK 14.8%→22.2%. Shadow defaults 3x. Competitors Allvue(CLO-only),Cascata(PE-only),spreadsheets(PC dominant). Wilmington 2026 confirms LME complexity increasing.
ops-tech:cross-vehicle-phased-rollout |CLO+BSL first(standardized,volume)→PC+BDC second(bespoke,growing)→evergreen third(smallest,highest complexity) |¬simultaneous |configurable-core+vehicle-specific-modules |by:loan-ops-tech-specialist |weight:primary
  |ctx: r1 F4. 3 distinct models: CLO(rules-based waterfall), BDC(SEC quarterly valuation ASC 820,$503B AUM +34% YoY), evergreen(continuous NAV). 3x complexity if simultaneous. No competitor has modular vehicle-specific arch.
ops-tech:Loan-IQ-strategy=own-core+API-integration |¬use-LIQ-as-primary |own waterfall+covenant+reporting engines=differentiation |Nexus as data bridge for bank counterparty exchange |GAP:validate launch volume justifies custom vs license |by:loan-ops-tech-specialist |weight:primary
  |ctx: r1 F8. Finastra ~70% global syndicated, 9/10 top banks. Bank agents use LIQ internally. Third-party must accept LIQ data but not constrained to use. LIQ limits: slow resolution(Gartner), not customizable. No third-party has built alternative core. Highest complexity decision—flagged for DA/lead review.
ops-tech:waterfall-claim-NARROWED |¬"no-platform-spans-BSL+PC"→"no-platform-integrates-loan-payment-waterfall+fund-distribution+CLO-compliance-in-single-admin-stack" |qashqade,LemonEdge,Cascade=PE-fund-distribution¬loan-admin-payment |NT-Omnium=CLO-compliance-bundled-w/custody |Allvue=CLO-only |loan-admin-payment-waterfall(priority-of-application)=distinct-from-fund-distribution-waterfall(carry/promote) |by:loan-ops-tech-specialist |weight:primary
  |ctx: r2 DA[#1] compromise. DA identified 5+ waterfall competitors. Research confirms all do fund distribution waterfalls(PE economics) or CLO compliance(OC/IC). None do loan admin payment waterfalls(fees→interest→principal→pro-rata sharing per credit agreement). Distinction is material and defensible.
ops-tech:Loan-IQ-GAP→PHASED-HYBRID |<50-facilities=license(Allvue-CLO+Cardo-covenant)+proprietary-payment-waterfall |≥50=begin-own-core |≥100=full-own-core |MVP-day-1:payment-priority-waterfall+accruals+notices+basic-settlement |resolves-F8-outcome-3-gap |by:loan-ops-tech-specialist |weight:primary
  |ctx: r2 DA[#7]+DA[#9] response. Cost: hybrid $3-6M/12mo vs full own-core $8-15M/24-36mo. Threshold-based migration reduces risk. Payment priority-of-application waterfall=unique admin function not available in any platform—must be proprietary from day 1.
build-sequence:DIVERGENCE-LOGGED |PS:distribution-first+minimum-viable-waterfall(GP-criteria:service-72%>tech-21%,GLAS-model) vs LOT:waterfall-first(calc-error=legal-liability=existential) |RESOLUTION-NEEDED:define-minimum-viable-waterfall-for-PC-deals |by:product-strategist+loan-ops-tech-specialist |weight:split
  |ctx: r2 DA[#5] forced identification of first genuine disagreement. PS-rationale:GP-selection=distribution-weighted+GLAS-built-$850B-via-service-THEN-tech. LOT-rationale:waterfall-accuracy=existential(single-error=financial+legal-liability+reputational-damage). Limited-capital($15-20M-Series-A)=can't-fully-fund-both-simultaneously.
regulatory:breakeven-mo-36-48(¬PS-30-42) |RLS-position:all-in-burn=$9.5-18.2M/yr(includes-reg-ops+distribution+charter-expansion-excluded-from-PS-F6) |need-190-364-facilities |divergence-with-PS-logged |by:regulatory-licensing-specialist |weight:primary
  |ctx: DA[#5] surfaced this disagreement. PS-F6 models $5-10.7M/yr burn but excludes: (1)regulatory-ops $1-2.5M/yr, (2)charter-expansion $1.5-3M/4yr, (3)distribution-build $3-5M/yr (PS's own F4). All-in burn=$9.5-18.2M/yr→need more facilities OR longer runway to breakeven. GLAS took 4yr to reach hundreds of facilities. This is a material disagreement for fundraising narrative (Series-A sizing, runway requirements).
regulatory:Hypercore-charter-moat-REDUCED |acquisition-path=9-18mo+$5-20M(¬28-45mo-de-novo) |moat:"significant"→"moderate" |chartered-Hypercore-advantage-NARROW(trustee-Day-1+BSL-readiness+law-firm-race) |by:regulatory-licensing-specialist |weight:primary
  |ctx: DA[#4] challenged SaaS-ceiling framing. Insight Partners ($90B+ AUM) has capital to acquire NH NDTC for Hypercore. OCC Feb 2026 approved multiple trust charters (favorable environment). Change-of-control 3-6mo + integration 6-12mo = 9-18mo total. Hypercore's $20B AUM at $2M avg deal ≠ mid-market BDC ($100M-1B), and SaaS DNA ≠ trust culture, but these are complications not barriers. New entrant must plan for chartered Hypercore scenario.
D[build-sequence]:waterfall+distribution=STAGGERED-CONCURRENT¬sequential. Waterfall-MVP(payment-priority+accruals+notices)=$3-5M-starts-mo-0. Distribution-BD-hiring-starts-mo-3-6. PS-either/or=false-dichotomy. Law-firms-require-ops-capability-for-referral(72%-GP-criteria="timely-accurate"). GLAS-precedent:ops-before-scale |by:loan-ops-tech-specialist |weight:HIGH(domain-expert-on-ops-sequencing)
  |ctx: DA[#5]-response:PS-disagrees(distribution-first),LOT-disagrees(waterfall-first)→compromise=staggered-concurrent
D[credit-cycle-pipeline-mix]:bear-case-pipeline=greenfield-15-20%+successor-40-50%+restructuring-20-30%+sponsor-10-15%. BDC-capital-formation-40%-YoY-decline-2026. Restructuring/workout-capability=MUST-BUILD-from-P1¬afterthought. Source:InvestmentNews,DFIN,Fitch(5.8%-default),Blackstone-redemptions |by:loan-ops-tech-specialist |weight:HIGH(ops-specialist+fresh-market-data)
  |ctx: DA[#3]-addendum:new-BDC-data-confirms-DA-was-right-credit-cycle-underweighted
exit-gate:PASS(r2)|synthesis-authorized |engagement:LOT(A-)+PS(B+)+RLS(A-) |challenges:8/10-held(80%) |4-gaps-resolved:cost-model($23-37M/$28-47M),Loan-IQ(phased-hybrid),credit-stress(bear-case),Hypercore(charter-scenarios) |2-divergences:build-sequence(PS-distribution-first-vs-LOT-waterfall-first)+breakeven(RLS-36-48mo-vs-PS-30-42mo) |1-correction:compliance-split(2/3-internal,1/3-external-KYC) |by:devils-advocate |weight:primary
  |ctx: r2-challenge-round-complete. 10-challenges-issued(4H+5M+1L). All-3-agents-responded-substantively. LOT-best-defense(waterfall-type-distinction). PS-best-honesty(owned-confirmation-bias). RLS-best-research(OCC-charter-surge-11-companies-83-days). No-additional-round-needed.
sigma-predict:RESEARCH-PROJECT¬PRODUCT-PROJECT |proposal-asks-"does-team-separation-improve-forecasts?"-which-is-research-question |evaluate-by-research-criteria(hypothesis-testable?,pilot-study-design?,kill-criteria?) ¬product-criteria(speed-to-market,competitive-baseline) |DA-challenge-#11-upheld:both-TA+PS-answered-wrong-question |grade-adjustment:proposal-design-quality-higher-than-initial-B- |by:devils-advocate+lead |weight:primary
  |ctx: r2-challenge-#11-META:agents-optimized-for-wrong-question. Proposal-line-7-explicitly-states-"determine-whether". Both-agents-graded-as-product-launch. DA-identified-question-substitution-pattern(new-team-pattern-stored).
sigma-predict:DUAL-TRACK-BUILD |Track-1(PRODUCT):competitive-bot-on-Metaculus-framework,enter-Spring-2026-tournament,establish-baseline |Track-2(RESEARCH):test-role-separation-hypothesis-incrementally-against-Track-1-baseline |neither-track-alone-is-sufficient:Track-1-without-Track-2=one-shot-bot¬learning-system,Track-2-without-Track-1=no-baseline-to-measure-against |by:lead |weight:primary
  |ctx: synthesizing-TA+PS-recommendation(competitive-bot-first)+DA-correction(proposal=research-project). Both-are-right:you-need-a-baseline-to-test-against(TA+PS)+you-need-to-actually-test-the-hypothesis(DA).
sigma-predict:REFRAME |goal=build-prediction-tool-focused-solely-on-prediction-quality |tournaments=validation-thermometer¬objective |¬product,¬market,¬sell,¬buy-in |experiment="can-we-actually-make+refine+improve-predictions-over-time" |architecture-agnostic:3-team-IF-it-produces-quality-predictions,alternative-IF-better |user-directive:rerun-review-with-prediction-quality-lens |by:user+lead |weight:directive
  |ctx: user-corrected-team-framing:agents-were-optimizing-for-tournament-entry+product-launch. User-clarified:sole-focus=quality-predictions. Metaculus-framework-bias-concern-raised-and-validated. Tournaments=measurement¬goal.
KB-docs-factual-accuracy: Doc3§1 rate data (Fed cuts 175bp, FFR 3.50-3.75%) is UNVERIFIABLE and potentially WRONG→must be verified against actual FOMC actions before publication. All downstream rate tables depend on this assumption. Doc3 Fedwire hours internally inconsistent (§4 says 7PM, §10 says 6:30PM). Doc6§12.1 WSO "industry-dominant" is INCORRECT→Finastra Loan IQ holds ~70% agent bank market share. |by:loan-ops-tech-specialist |weight:primary
  |ctx: KB review r1 — factual accuracy assessment of loan admin training documents. Domain authority: loan ops technology, settlement, payment systems, platform market share.
KB-docs-completeness-gaps: 5 material gaps identified for third-party agent curriculum: (1) borrowing request/funding notice lifecycle [HIGH→foundational daily workflow], (2) payment waterfall/priority of payments [HIGH→every distribution depends on this], (3) agent fee structures/billing mechanics [MH], (4) lender register maintenance [MH→legal significance], (5) intercreditor agreement agent operations [M]. Additionally, escrow agent coverage is 1 paragraph for a role explicitly in curriculum scope. These gaps represent "operational how-to" content vs the "conceptual what/why" that docs cover well. |by:loan-ops-tech-specialist |weight:primary
  |ctx: KB review r1 — completeness assessment against third-party agent (admin+collateral+escrow) curriculum requirements.
glossary-is-highest-priority: for any multi-doc curriculum with 100+ specialized terms, a consolidated glossary is the single highest-impact structural improvement |rationale: enables independent doc access, reduces prerequisite burden, supports non-linear learning paths |implementation: Doc0_Glossary.md with terms + definitions + "first introduced in DocN §M" refs |cost: 4-6 hours |benefit: every trainee on every doc access |by:technical-writer |weight:primary
  |ctx: loan admin KB review r1 — 6 docs, 378KB, 100+ terms, no glossary
Doc5 regulatory content verified HIGH accuracy (21/22 web-confirmed). Only factual error: OFAC penalty $330,947→$377,700 in Doc6§6.3. Agent licensing framework=MOST SIGNIFICANT regulatory gap — recommend new Doc6 section covering trust charter, non-chartered agent, bank subsidiary regulatory status. |by:regulatory-licensing-specialist |weight:primary
  |ctx: R1 regulatory review of 6 loan administration knowledge base documents for third-party admin/collateral/escrow agent training curriculum
D[r2-exit-gate-PENDING|19 challenges issued, agent responses required before synthesis authorization|must-resolve: (1)LOT Fedwire correction error, (2)priority re-ranking by trainee impact, (3)curriculum design positions(BSL+PC, exercises, VERIFY tags)|exit-gate will PASS if agents engage substantively with challenges|26.3.13] |by:devils-advocate |weight:primary
  |ctx: loan-admin-KB-review r2 challenge round. 3 agents delivered strong r1 findings (64F+16G). Zero divergence(5th consecutive). DA issued 19 challenges focusing on: correction accuracy, priority ranking methodology, curriculum design questions, scope boundaries.
KB-review-priority-framework: trainee-impact>analytical-severity. CRITICAL=missing-operational-workflows(G1-borrowing-request,G2-payment-waterfall)→trainees-cannot-do-core-job. HIGH=operational-gaps(register,fees,escrow,intercreditor,LME-playbook)+factual-errors-affecting-operations(Fedwire-cutoffs,WSO-vs-LoanIQ). MEDIUM=factual-errors-in-reference-data(rates,stats). LOW=enhancements. Completeness-gaps-collectively-outweigh-factual-findings. Deliverable-structure: (1)new-content-WRITING, (2)factual-corrections-EDITING, (3)enhancement-ITERATIVE. |by:loan-ops-tech-specialist |weight:primary
  |ctx: KB review r2 — DA challenge #2 and #3 prompted re-ranking from analytical-severity to trainee-impact basis. User input: audience=new hires (Ops, RMs, engineers, product) at non-trust-company third-party agent.
D[r2-exit-gate-PASS|synthesis authorized|grades:LOT(A-),TW(A-),RLS(A)|19 challenges→16 held,2 defended,1 fell|key outcomes: Fedwire corrected, priority restructured, G2 withdrawn, VERIFY 3-tier policy, duty-source framework, §6.2 proportionality review|26.3.13] |by:devils-advocate |weight:primary
  |ctx: loan-admin-KB-review r2 exit-gate evaluation. All 3 agents addressed all 19 challenges substantively. Engagement quality A- or above across all agents. No material disagreements unresolved. No untested consensus remaining (VERIFY policy stress-tested by design, doc structure logged as deliberate non-action).
loan-admin-KB-review: 7 factual corrections, 9 critical operational gaps, 20 enhancements identified across 6 docs (~378KB). Priority: factual corrections > operational gaps (new writing) > structural improvements > enhancements. Key pattern: analyst-perspective bias — docs strong conceptual, weak operational. DA exit-gate PASS (3-round review). Grades: LOT(A-), TW(A-), RLS(A), DA(84% hit rate, 2 self-corrections). User scoping: non-trust-company, new hires novice→near-expert, pure KB (no exercises), structure fully flexible, [VERIFY] tags stay with 3-tier policy. |by:sigma-lead |weight:primary
  |ctx: sigma-review of 6 loan administration knowledge base documents for third-party agent curriculum. 4-agent team (loan-ops-tech-specialist, technical-writer, regulatory-licensing-specialist, devils-advocate). 3 rounds (r1 research, r2 DA challenge + response, exit-gate PASS).

## WU market analysis r1 (26.3.13)

geopolitical:compounding-corridor-risk-framework |by:geopolitical-strategist |weight:primary
  |ctx: immigration enforcement+excise tax+national FPS analyzed as interacting forces ¬independent risks. Individual estimates: tax alone -1.6%, sender erosion -3% to -5%. Combined: -5% to -8% US corridor volume. IAD+IIF+Brookings+WU own data converge. Standard analyst reports treat risks independently→understate
  |alt: independent-risk-model(sum separately)|worst-case-aggregation(too pessimistic)|correlation-adjusted(insufficient data for coefficients)

geopolitical:sanctioned-corridor-loss-permanence |by:geopolitical-strategist |weight:primary
  |ctx: Russia exited Mar 2022→A7A5 stablecoin processed $93.3B in <1yr. Iran $7.78B crypto ecosystem, +694% YoY sanctions evasion. Once crypto fills corridor at scale, formal channels don't recover. Syria reopening (Jul 2025)=rare exception, smaller corridor
  |alt: temporary-loss(wait for sanctions removal)→REJECTED(Russia crypto replacement proves permanence)

geopolitical:USDPT-compliance-paradox-flagged |by:geopolitical-strategist |weight:advisory
  |ctx: WU entering stablecoin space while stablecoins=84% of illicit crypto volume+primary sanctions evasion tool. Regulated USDPT competes with unregulated alternatives that serve corridors WU legally cannot. Regulatory scrutiny risk. §2c gap: cannot assess full compliance cost across jurisdictions→flagged for regulatory-licensing-specialist

regulatory:GENIUS-Act-net-negative-for-WU-moat |by:regulatory-licensing-specialist |weight:primary
  |ctx: GENIUS §5(h) preempts state MTL for FQPSIs+IDI subsidiaries. WU's 50-state MTL=$200M/yr was asymmetric barrier. Post-GENIUS, Circle+Ripple+Paxos+BitGo+Bridge/Stripe bypass with $5M min capital(OCC NPRM). WU gains USDPT enablement but loses regulatory exclusivity. K&L Gates+Mayer Brown: preemption "self-executing." Remaining moat=physical(360K locations) ¬regulatory
  |alt: GENIUS-net-positive(WU investor narrative)→REJECTED|GENIUS-neutral→REJECTED(asymmetric loss > symmetric gain)|moat-intact(GENIUS=stablecoin-only)→PARTIALLY-VALID near-term but stablecoin substitution growing

regulatory:USDPT-compliance-$15-30M/yr |by:regulatory-licensing-specialist |weight:primary
  |ctx: resolves geopolitical-strategist F8 §2c gap. Issuance=Anchorage(FQPSI,$0 to WU)+partnership fees $5-15M/yr. Distribution=WU bears(GENIUS preemption scope unclear per Mayer Brown). EU/MiCA=$3-8M. Per-country=evolving. Total=$15-30M/yr. WIDE error bars—regulation evolving
  |alt: lower-estimate($5-10M,US-only)→REJECTED(multi-jurisdiction necessary)|higher-estimate($30-50M)→possible if EU/APAC regulation tightens

regulatory:moat-shift-regulatory→physical+brand+data |by:regulatory-licensing-specialist |weight:primary
  |ctx: GENIUS preemption+MTMA 41 states+OCC charter surge converge on regulatory barrier reduction. WU's durable moats shift to: (1)360K physical locations(no competitor replicates), (2)brand trust(175yr), (3)KYC/AML data assets($200M/yr compliance infrastructure). Morningstar already downgraded wide→narrow (2023)
  |alt: regulatory-moat-persists→REJECTED(3 vectors eroding simultaneously)|physical-moat-also-eroding→PARTIALLY-VALID long-term(demographics shift digital) but 5-10yr+ horizon

portfolio:capital-allocation-97%-impedes-transformation |by:portfolio-analyst |weight:primary
  |ctx: FY2025 OCF $544M, returns $529M(97%). Peers 15-25% rev growth investment vs WU ~6-8%. FCF/div 1.29x(thin). Recommend 60-70% return ratio→frees $130-160M/yr. Maintain $0.94 div, halt buybacks >$100M
  |alt: maintain-current(yield-supports-stock)→REJECTED(unsustainable for transforming company)|full-harvest(maximize-returns)→considered if moat eroding

portfolio:Intermex-accretive-declining-corridor |by:portfolio-analyst |weight:primary
  |ctx: $500M for declining asset(Intermex txns -8.5%, US-Mexico <1% 2026). Financially accretive(>$0.10 EPS, $30M synergies). Strategically questionable(consolidation≠growth). Leverage 1.6→2.1x. Upside: 6M customer digital cross-sell at $20-30 CAC
  |alt: pass-on-Intermex→valid but 6M customers hard to replicate organically

portfolio:valuation-asymmetric-at-4.2x |by:portfolio-analyst |weight:primary
  |ctx: P/E 4.2x prices perpetual decline. Down(-4%+cut)=$6-7. Up(stabilize)=$12-14. ~1.5:1 upside. PayPal 8.6x=achievable comp=100% upside. Organic rev ex-Intermex=acid test for re-rating
  |alt: fair-value(decline-priced-correctly)→possible|turnaround-play→requires catalyst

portfolio:dividend-proactive-cut-policy |by:portfolio-analyst |weight:primary
  |ctx: FCF/div 1.29x(THIN). Maintain $0.94 through '26-'27. IF organic growth fails Q4 2027→proactive cut $0.70(~7% yield)→redirect $85M/yr. Proactive > reactive. SA confirms "unsustainable late 2027"
  |alt: maintain-indefinitely→REJECTED(1.29x inadequate)|cut-now→too-aggressive(lose yield holders without proving turnaround)

## WU market analysis r1 — tech-industry-analyst decisions (26.3.13)

tech:rails-war=structural-threat |by:tech-industry-analyst |weight:primary
  |ctx: 4 L1 payment chains (Stripe Tempo $5B, Circle Arc 150M txns testnet, Google GCUL CME phase 1, Solana $650B/mo) all confirmed 2026. Combined capital >$100B. Enterprise blockchain 2-3yr slower but testnets LIVE. WU must adopt multi-rail strategy. Single-chain=HIGH risk.

tech:AI-compliance-moat-eroding |by:tech-industry-analyst |weight:primary
  |ctx: WU $200M/yr compliance becoming stranded cost. McKinsey 200-2,000% productivity gains. Sardine 88% auto-resolution. Felix 48hrs→<5min. GENIUS+AMLA harmonization reduces complexity. New entrants at 30% WU cost. Moat=table-stakes 2-3yr. Must invest $100-200M/3yr modernization.

tech:SWIFT-retail=primary-real-time-threat ¬FedNow |by:tech-industry-analyst |weight:primary
  |ctx: SWIFT Payments Scheme Jun 2026: enforceable cross-border retail rules, 25+ banks, 11 countries (AU,BD,CA,CN,DE,IN,PK,ES,TH,UK,US). FedNow domestic-only=indirect. SWIFT corridors overlap 80%+ WU top corridors. Bank-native lower CAC. gpi 89% traffic adoption within 4yr validates timeline.

tech:WU-stablecoin-follower ¬leader |by:tech-industry-analyst |weight:primary
  |ctx: MoneyGram LIVE Colombia USDC/Stellar. Felix Pago LIVE WhatsApp USDC $1B+. Remitly One Sep 2025 stablecoin wallet. WU USDPT announced Oct 2025, H1 2026 ¬yet live. 12-18mo behind. Visa USDC Solana $3.5B annualized. WU's 360K off-ramp=genuine moat but execution gap real.

## WU market analysis r1 — sanctions-trade-analyst decisions (26.3.13)

sanctions:compliance-moat-depreciating-asset |by:sanctions-trade-analyst |weight:primary
  |ctx: $200M/yr AML validated by Binance $4.3B+TD Bank $3B fines. BUT DOJ "Ending Reg by Prosecution" Apr 2025+GENIUS Act floor+AI(Verafin 80% reduction) compress costs. Moat narrows from both directions. 20yr×200-country data=irreplaceable ML asset. Must convert spend→CaaS product within 3-5yr or 500bp margin disadvantage vs AI-first competitors by 2029
  |alt: maintain-as-cost-center→500bp gap|license-immediately→dilutes advantage|selective-via-DAN→current approach,implicit ¬explicit

sanctions:GENIUS-§16d-MTL-moat-bypass |by:sanctions-trade-analyst |weight:primary
  |ctx: §16d preempts state MTL for stablecoin issuers. OCC NPRM Feb 2026→finals Jul 2026→entry mid-2027. PayPal PYUSD operational, JPMorgan positioning. WU correct to use Anchorage(OCC-chartered) but competing on new terrain. Davis Polk+Arnold Porter+K&L Gates+Gibson Dunn all confirm preemption scope. CONFIRMS+DEEPENS regulatory-licensing-specialist decision on GENIUS-net-negative
  |alt: MTL+stablecoin(current,$30-50M/yr)|stablecoin-primary(risk:cash still needs MTL)|dual-track(optimal but complex)

sanctions:sanctions-enforcement-paradox-dual-framing |by:sanctions-trade-analyst |weight:primary
  |ctx: $104B sanctioned crypto(Chainalysis 2026,+694%) VALIDATES compliant alternatives(WU USDPT) AND THREATENS by proving uncompliant stablecoins scale without consequences. OFAC effective centralized(Zedcex,Binance)|ineffective decentralized(Tornado Cash 5th Cir). WU regulatory pitch: "our stablecoin has same AML as legacy." Both framings correct simultaneously—consensus overweights threat, underweights validation
  |alt: threat-only(consensus)→incomplete|validation-only(WU narrative)→naive|dual-framing(our position)→captures both dynamics

## WU market analysis r3 — portfolio-analyst DA responses (26.3.13)

valuation:probability-weighted-fair-value-$9.90-13.00 |by:portfolio-analyst |weight:primary
  |ctx: 4-scenario model(success 15-20%/$15-18, stabilization 35-40%/$11-13, managed decline 30-35%/$8-9, accel decline 10-15%/$5-7). Current $9.73=fairly priced to modest undervalue. ¬deep value. Upside requires catalysts(organic growth proof, CS acceleration). Beyond 2028 success=best case $4.6B ¬$5B. DA[#7] compromise.
  |alt: dismiss-Beyond-2028(r1 position)→corrected|model-success-only→overweights|current(probability-weighted)→balanced

capital:integrated-transformation-$798M-5yr-fundable |by:portfolio-analyst |weight:primary
  |ctx: de-duplicated 4 agents' overlapping estimates. Tech $490-870M INCLUDES AI+USDPT→¬additive with sanctions $100-200M or reg-lic $15-30M/yr. Fundable from OCF($786M capex)+buyback redirect($525M). No div cut or new debt. !CRITICAL: -4%/yr decline→OCF erosion $50M/yr→deficit yr3-4→forced div-vs-transformation. DA[#8] concede.
  |alt: sum-all-estimates($1.2B+)→double-counted|tech-only($490-870M)→misses ongoing compliance|integrated($798M)→realistic

## warehouse LMS market analysis r1 — product-strategist decisions (26.3.14)

product:unified-human+robot-LMS=genuinely-unoccupied-category |by:product-strategist |weight:primary
  |ctx: 4-tier competitive landscape(WMS-embedded~60%,standalone~25%,WFM-adjacent,robotics-bundled). Zero vendors offer blended human+robot cost-per-unit in single dashboard. Locus=closest(patent-pending AI coordinating people+robots,LocusONE) BUT robot-fleet-only ¬third-party. DHL:44%-deployed-robotics,34%-satisfied=gap-evidence. Orchestration platforms treat human+robot as separate systems
  |alt: Locus-expands-to-full-LMS(6-12mo-risk)|WMS-incumbents-add-robot-APIs(bolt-on ¬purpose-built)|wait-for-market-to-form(lose-window)

product:3PL-mid-market-greenfield-robotics=entry-segment |by:product-strategist |weight:primary
  |ctx: 3PL-mid-market(100-500-employees): highest-labor-cost-pressure(50-70%-budget), WMS-agnostic-need(multi-client), fastest-robotics-adoption(33.7%-AI-2026,2x-2023), 4-week-onboard-benchmark(Takt). Greenfield-robotics-adopters=beachhead(79%-plan-robotics-by-2026,existing-LMS-has-zero-robot-awareness). US-first($310B-3PL-market). ¬enterprise(Manhattan/BY-lock-in). ¬SMB(Easy-Metrics-600-dominant,low-ACV)
  |alt: enterprise-first(blocked-by-WMS-lock-in)|SMB-first(low-ACV-unsustainable)|robotics-vendor-first(dependency)

product:BUILD-primary-$8-13M-to-first-revenue |by:product-strategist |weight:primary
  |ctx: alternatives-analyzed: BUILD($5-8M-MVP-18mo+$3-5M-GTM=$8-13M), ACQUIRE-Easy-Metrics($50-100M+,600-facilities,legacy-arch), ACQUIRE-Takt(earlier-stage,lower-cost,smaller-base), PARTNER-Locus(defer-12mo,evaluate-trajectory), NULL(¬recommended,$719M→$3.72B-market). BUILD=purpose-built-unified-architecture-from-day-1. Easy-Metrics=evaluate-actively-for-distribution-not-tech
  |alt: acquire-Easy-Metrics-for-distribution(expensive,$50-100M+)|partner-Locus-for-integration(dependency-risk)|null(miss-genuine-gap)

product:differentiation-window=6-12mo |by:product-strategist |weight:primary |REVISED-r2:3-6mo(features)/12-18mo(positioning)
  |ctx: Locus-patent-pending-AI-human+robot+Array-R2G-shipped=trajectory-toward-full-LMS. WMS-incumbents-adding-robot-modules. Consensus-forming-on-human+robot-coordination-as-bolt-on. Purpose-built-unified-model=12-18mo-advantage-over-bolt-on. Feature-parity-on-coordination-within-24mo. MUST-have-MVP-within-12mo
  |r2-revision: BY-Robotics-Hub-already-shipping-vendor-agnostic-robot+human-orchestration. Window-SHORTENED. Feature-gap=3-6mo(BY-could-add-cost-per-unit). Market-positioning-gap=12-18mo(BY-going-downmarket-slow). DA[#2]-compromise
  |alt: window-longer(18-24mo)|window-shorter(<6mo,Locus-moves-faster-than-expected)

## warehouse LMS r2 — product-strategist DA-response decisions (26.3.14)

product:unified-LMS=CONTESTED-¬unoccupied |by:product-strategist |weight:primary |REVISED-from-r1
  |ctx: BY-Robotics-Hub(vendor-agnostic,human+robot-workload-balancing,+22%-labor-productivity), Locus-LocusINTELLIGENCE(system-directed-labor-optimization,worker-dashboards), Manhattan(unified-resource-orchestration+Agility-humanoid). 3 incumbents converging from adjacent positions. r1 missed BY entirely=research failure. Remaining gap=narrow: cost-per-unit-economics+mid-market-pricing+WMS-independence
  |DA: DA[#1]-concede,DA[#11]-concede(§2a-failure)
  |alt: gap-already-closed(bearish)|gap-still-meaningful(our-position)|gap-permanent(overly-bullish)

product:capital-requirements-$6-10M-pre-revenue |by:product-strategist |weight:primary |REVISED-from-r1($8-13M)
  |ctx: MVP=12-14mo+sales-cycle=mo-14-18-first-customer. Y1-from-founding=$0. Y1-from-launch=4-6-customers=$384K-1.08M-ARR-by-mo-24-30. Burn-pre-revenue=$6-10M. Seed=$4-6M(MVP-only). Series-A-required-before-first-revenue. 50%-increase-from-r1-estimate
  |DA: DA[#5]-compromise
  |alt: bootstrap(impossible-at-this-burn)|single-round($10-15M-seed,rare)|staged(seed+A,our-position)

product:Easy-Metrics-acquisition=¬startup-viable |by:product-strategist |weight:primary |REVISED-from-r1($50-100M)
  |ctx: 600+-facilities,$60-100M-implied-ARR,3-5x-SaaS-multiple=$180-500M. Only-viable-for-PE/strategic. Takt=$20-50M=more-plausible-for-well-funded-startup
  |DA: DA[#10]-concede
  |alt: Easy-Metrics-overvalued(possible-but-600-facilities-commands-premium)|Takt-available(evaluate)

risk:political-risk-elevated-to-CRITICAL |by:portfolio-analyst |weight:primary
  |ctx: excise tax+immigration compound -$80-320M/yr. Extreme scenario(expanded tax+mass deport) -$450-550M by 2028=-11-13% rev→div unsustainable+transformation unfundable. #1 near-term risk ahead of stablecoin. Precautionary surge masking base erosion→12-18mo cliff. DA[#3] concede.
  |alt: maintain-HIGH(r1)→underweights current impact|CRITICAL(revised)→matches evidence

network:corridor-specific-moat-model |by:portfolio-analyst |weight:primary
  |ctx: 360K=¬monolithic. Asset corridors(CentAm,Gulf-SA,SSA)=180-200K stable=genuine moat. Liability corridors(US-India,Eur,urban US)=150-180K declining. Feedback loop threshold ~250-300K. Cloud POS rev/loc $10.8K→$13.0K supports transformation thesis. CONFIRMS econ-F3. DA[#5] compromise.
  |divergence: PS assigns 30% success probability vs portfolio 15-20%—healthy tension, PS weights execution evidence heavier
energy:tradeable-range-revised-AGAIN |r3 $85-120→rerun $95-120+ |SPR 400M deployed+FAILED to suppress(Brent >$100) |conditional floor raised: r3 $80-85 WITH SPR→$95+ WITH SPR deployed+ineffective |demand ceiling $120 maintained(r3) but onset delayed |by:energy-market-analyst |weight:primary
  |ctx: rerun 26.3.13. IEA announced+deployed largest ever 400M bbl release on 3/11. Brent dipped temporarily then returned >$100 by 3/13. Market pricing sustained disruption through SPR. 14 days Hormuz closed, 5-ship attack on 3/11=escalation. Polymarket ceasefire by Mar31 dropped 61%→24%
energy:refiners-UPGRADED |"nuanced-watch"→"strong-tailwind"|crack spreads $18.65→$40/bbl(+114%)|MPC 114% capture|refiner-supercycle-thesis-credible |NEW position recommendation for portfolio |by:energy-market-analyst |weight:primary
  |ctx: rerun 26.3.13. Benzinga: "Iran war created earnings boom for US refiners." $40/bbl crack spread implies $268B annualized gross margin potential across US refining. MPC,VLO,PSX up 31-40% YTD. MPC $2.7B OCF in Q4(+60% YoY). Even normalized $25 crack=$168B. Historical supercycles(2022) lasted 12-18mo
energy:SPR-effectiveness-DOWNGRADED |r3 estimated $5-8 price impact→ACTUAL: temporary dip then rebound above $100 |market calling SPR bluff |400M over 120 days=3.3M bpd vs 14-15M bpd stranded=22% of shortfall |insufficient rate AND volume |by:energy-market-analyst |weight:primary
  |ctx: rerun 26.3.13. IEA 400M bbl announced 3/11, US 172M over 120 days=1.43M bpd. Total coordinated ~3.3M bpd. Hormuz normally transits 20M bpd. Net stranded after bypass(4-6M)+SPR(3.3M)=still 7-10M bpd short. Market correctly pricing SPR as insufficient
sanctions:Hormuz-bifurcation-model-replaces-binary-closure |by:sanctions-trade-analyst |weight:primary |ctx: Hormuz is ¬binary open/closed but segmented. Shadow fleet(50%+ transits)+Iran exports(1.25M bpd to China) operating under AIS suppression+IRGC escort. Commercial/insured fleet blocked by insurance withdrawal(P&I voided Mar 5)+attack risk(16+ vessels struck). Creates two-tier oil market with different pricing. Replaces r1/r3 total-closure assumption. Supply models must account for continued Iran-China flows |alt: total-closure(r1 model)→REJECTED by evidence|selective-closure(IRGC statement)→CONFIRMED by shipping data |by:sanctions-trade-analyst |weight:primary
  |ctx: Iran exporting 1.25M bpd through Hormuz to China via shadow fleet despite blockade. 11.7M+ bbl shipped since Feb 28. IRGC policy: closed to US/Israel/Western allies only. Shadow fleet=50%+ of all Hormuz transits.
sanctions:bypass-capacity-REVISED-UP |8.3M bpd OPERATIONAL day 14(was r3 4-6M initial estimate) |Saudi Petroline 7M bpd full capacity Mar 11+UAE Habshan-Fujairah 1.8M full |alt port loadings 6.52M bpd(+80% WoW) |by:sanctions-trade-analyst |weight:primary |ctx: Saudi+UAE activated bypass faster than ANY prior estimate. r1: 4-6M, r3: 4-6M initial→5-7M by month 3-6. ACTUAL: 8.3M by day 14. Iraq/Kuwait 5M+ still permanently stranded(zero bypass). Net disruption ~10M bpd ¬20M theoretical |by:sanctions-trade-analyst |weight:primary
  |ctx: Saudi Petroline converted to full 7M bpd capacity Mar 11. UAE Habshan-Fujairah at full 1.8M bpd. Red Sea loadings +80% WoW to 6.52M bpd. Bypass operational at 8.3M bpd total by day 14 of crisis.
sanctions:enforcement-ceiling-exists |OFAC ¬escalated to Chinese banks/CIPS despite active war |vessel sanctions=current enforcement ceiling |bank sanctions=nuclear option constrained by US-China trade politics |IF deployed→0.6-0.8M bpd additional disruption→Brent $105-125 |by:sanctions-trade-analyst |weight:primary |ctx: 3 teapots+3 port operators SDN'd but ¬banks. Escalation ladder: teapots→ports→banks→CIPS. War has not triggered escalation beyond ports. Political calculus: tariff negotiations+China strategic relationship constraining OFAC |by:sanctions-trade-analyst |weight:primary
  |ctx: OFAC has not targeted Chinese banks processing Iran oil payments despite active war since Feb 28. Escalation ladder available but politically constrained.
portfolio:v5-MPC-refiner-add |energy 11→12%(+1pp MPC 1%)|crack spreads $18.65→$40/bbl(+114%), 114% capture rate|exit trigger: Brent<$90+cracks<$25|stop $170 |by:portfolio-analyst |weight:primary
  |ctx: energy-market-analyst F12 identified crack spread explosion. Portfolio-analyst confirmed MPC as individual name ¬ETF(less crowded). Refiner supercycle: 2004-2006(30mo),2022(12mo) precedents. Current $40 95th percentile historically. +31-40% YTD partially priced but Q1 earnings leverage massive vs Q4 $18.65 base
portfolio:ceasefire-bucket-reduced |7→5%(-2pp)|near-term ceasefire probability DOWN(Polymarket Mar31: 24%, Iran FM rejected, mines planted)|sustained-conflict 50-55% BASE CASE |by:portfolio-analyst |weight:primary
  |ctx: v4 added 7% ceasefire bucket on DA recommendation(35-40% prob). Rerun: near-term ceasefire DOWN(Iran FM rejection+mine planting+Mojtaba consolidation). Polymarket Apr30 78%=eventual but timing extended. Redirect 2pp to energy(+1pp MPC)+cash(+1pp)
portfolio:scenario-weights-revised |sustained 40-45→50-55%, ceasefire 15-18→10-15%, escalation 15-20→20-25%, stagflation 5-8→10-15% |30d horizon |by:portfolio-analyst |weight:primary
  |ctx: Iran FM rejected ceasefire. Mojtaba Khamenei consolidating. Naval mines planted in Hormuz. SPR 400M deployed+failed. Goldman 25% recession. Yardeni 35% stagflation. Polymarket Mar31 ceasefire 24%(down from 61%). Hormuz day 14 still closed. 5 ships attacked 3/11. War ESCALATING ¬de-escalating
geopolitical:ceasefire-probability-REVISED-DOWN|18-26%(was 30-38%)|Polymarket converged toward our assessment(24% Mar31)|Mojtaba maximalist+Iran FM rejected+Lebanon front+Marines deploying|combined sustained+ 70-84% |by:geopolitical-strategist |weight:primary
  |ctx: rerun Day 14: r3 ceasefire 30-38% revised DOWN based on: Mojtaba first statement maximalist(no off-ramp), Iran FM rejected negotiation, Pezeshkian non-starter demands, Lebanon front opened, Marines deploying, Oman backchannel ¬productive since 3/10. Polymarket collapsed 61%→24%(Mar31) TOWARD our position
geopolitical:proxy-model-REVISED|uniform-decay→selective-activation|Hezbollah=ACTIVATED(full war),Houthis=RESTRAINED(Trump deal),Iraq=DECLINING|each proxy independent trajectory |by:geopolitical-strategist |weight:primary
  |ctx: rerun Day 14: r3 decay curve(M1 85%→M3 40-45%) was too uniform. Hezbollah ACTIVATED by Israel ground ops=full-scale Lebanon war(773 killed). Houthis STILL restrained by Trump deal. Iraq declined from Day 1-3 peak. Oman spillover(2 dead). Each proxy on own trajectory based on domestic constraints+Israeli targeting
geopolitical:Hormuz-timeline-EXTENDED|Phase-0→1: 2-4wk from Day 14(¬war start)|Phase-3: 12-20wk|Navy "not ready"|mine-clearing ¬begun|BIFURCATED: shadow fleet transiting, commercial blocked |by:geopolitical-strategist |weight:primary
  |ctx: rerun Day 14: Phase-0 persisting, no conditions for transition met (cessation of ship attacks, naval reallocation, mine-clearing). Energy Sec Wright: "not ready". Pentagon admitted underestimating. Mojtaba: "must remain closed". Bifurcation finding from sanctions-trade-analyst integrated. 5-phase model CONFIRMED structurally but extended temporally
stagflation:probability-revised-UP |30-35%→40-50% |Q4 GDP 0.7%(revised from 1.4%)+PCE 2.8%+oil $103+NFP -92K+UE 4.4%=multiple simultaneous signals |Deutsche Bank+Oxford Economics explicitly warning |Goldman recession 25% |analog: 1990 IF <3mo, 1973 IF prolonged |by:macro-rates-analyst |weight:primary
  |ctx: rerun analysis 26.3.13. Q4 GDP revision released TODAY was critical new data ¬available in r1. Combined with oil $103(was $91), ceasefire prob DOWN(24% vs 52%), all 5 stagflation indicators now flashing simultaneously
rates:fed-cut-path-dead |only Dec 2026 priced(was 2-3 cuts r1) |CME 94.1% hold Mar 18 |energy inflation blocks cuts |Warsh transition May 15 creates policy gap |rate-sensitive sectors TRIPLE headwind(no cuts+inflation+growth↓) |by:macro-rates-analyst |weight:primary
  |ctx: rerun 26.3.13. Market pushed cuts from Jul→Sep→Dec. KRE -5% on GDP revision day. P[oil-shock→fed-paralysis] pattern from r1 fully confirmed
portfolio:TLT-ceasefire-timing-wrong |TLT underperforming at 4.28% 10Y |ceasefire prob DOWN 52→24% |REVISED: cash>TLT near-term |TLT calls for asymmetric ceasefire payoff instead of linear exposure |by:macro-rates-analyst |weight:primary
  |ctx: r3 ceasefire bucket had TLT 3%. Since then 10Y rose 4.13→4.28% while ceasefire prob fell. TLT is losing money in war scenario AND not positioned optimally for ceasefire. Options provide better risk/reward
DA-r2-exit-gate: PENDING |12-challenges-issued(2!C,5H,4M,1L+) |engagement-pending-agent-responses |MUST-address: (1)ceasefire-crash-modeling-with-Mar-11-data, (2)DFC-reinsurance-assessment, (3)energy-crowding-behavioral-change, (4)scenario-probability-reconciliation, (5)SPR-timeline-correction |by:devils-advocate |weight:primary(bias-detection)
  |ctx: Iran-conflict-rerun-r2 |5-agents-69-findings-0-disagreements |DA-independent-research-found-6-counter-evidence-items-not-in-workspace(DFC-program,Mar-11-crash-data,pre-conflict-surplus,demand-destruction-magnitude,crack-spread-history,stagflation-base-rates)
energy:tradeable-range-revised-r2 $88-115 time-dependent(Mo1 $88-115,Mo2 $85-105,Mo3-4 $80-95)|was $95-120+|floor DOWN $88-92(bypass overperformance+SPR gradual+demand destruction)|ceiling DOWN from demand destruction self-limiting|energy-complex ≤18%(was 23%)|SPR "early-stage uncertain"(was "FAILED")|crack "conflict-driven expansion"(was "supercycle")|DFC reinsurance=new 30-40% downside risk |by:energy-market-analyst |weight:primary
  |ctx: R2 DA challenge responses: 4 full concessions(crowding,ceasefire crash,demand destruction,SPR premature)+1 omission(DFC)+2 compromises(floor,cracks). All 8 challenges produced outcome-1 revisions. Genuine disagreement offered on sanctions-trade bypass ceiling(Iraq/Kuwait 5M irreducible)
v5→v6 energy-complex 23→19%: XLE halved(crowding), MPC+BNO removed. TRUE crowded exposure 9%(was 13%). MLPs defended as infrastructure income ¬crowded energy |by:portfolio-analyst |weight:primary
  |ctx: DA[#1] crowding challenge. XLE $1.81B inflows, CFTC 172K net long. Conceded ETF+commodity most crowded, defended E&P+MLP+tanker on independent drivers
ceasefire drawdown RE-MODELED using Mar 11 data: base -3.5/-5.4%, severe -5.5/-8.2%(was -2.5/-4%). Speed=primary risk. FANG/EOG puts added to hedge |by:portfolio-analyst |weight:primary
  |ctx: DA[#2] ceasefire crash challenge. Mar 11 Brent -12% on rhetoric alone. v5 estimate contradicted by observed data. Full re-model with component-level stress test
scenario probabilities RECONCILED: portfolio adopts geopolitical framework. Sustained 42-47%(was 50-55%), ceasefire 18-26%(was 15-23%). Geopolitical=domain primary for scenarios |by:portfolio-analyst |weight:primary
  |ctx: DA[#7] divergence challenge. 10pp gap on sustained was double-counting—geopolitical already incorporated SPR+mines+Mojtaba. Portfolio role=translate probabilities to weights ¬re-estimate geopolitical outcomes
DA exit-gate PASS for Iran conflict rerun R2. v6 portfolio DA-tested. Synthesis-ready with 5 risk factors: crowding unwind amplification, time-dependent portfolio adjustment, DFC probability low-confidence(15-25% 30d ¬30-40%), post-conflict overshoot($55-65), MLP §2c gap. 3 deliberate divergences logged: tradeable range(energy $88-115 vs sanctions $85-110), bypass permanence(portfolio disputes sanctions), price range perspective(macro $95-110 vs energy $88-115) |by:devils-advocate |weight:primary(DA exit-gate authority per directives)
  |ctx: R2 exit-gate evaluation. 12 challenges issued, 8 held/partially held(67%). All agents ≥B+. Portfolio v5→v6: energy equity -4pp, MPC+BNO removed, drawdown re-modeled -5.5/-8.2%. Analytical quality highest evaluated on this team

## §6g temporal contamination controls (26.3.15)

governance:§6g-temporal-boundary |by:lead |weight:primary
  |ctx: SVB Jan 2023 stress test revealed §6 v1.0 designed for topic contamination ¬temporal. 3 vectors: (1) web search returns post-event sources+summaries (2) model training knowledge includes outcomes (3) confidential-then-public info leaks. 0/14 non-filing sources pre-cutoff, CAMELS ratings (confidential) appeared as findings, probability estimates showed hindsight anchoring
  |decision: §6g added to directives v1.1 — 6 sub-protocols: boundary-declaration, agent-firewall, source-date-audit, temporal-scan, DA-hindsight-check, provenance-requirements. Model-knowledge capped at M confidence. >25% source rejection triggers finding re-examination. Integrated into sigma-lead.md+SKILL.md
  |scope: ¬critical for standard market reviews, critical for retrospective/scenario/stress-test analyses
  |lesson: governance layer only works when reviews route through skill→lead→directives chain. Direct agent spawns bypass all controls
SVB business model risk as of 2023-01-31: HIGH — active deposit outflow (-13% from Q1 2022 peak), 94% uninsured deposits (highest peer), 60% sector concentration, VC funding winter accelerating drawdown (-37% US VC 2022 YoY), NII-dominant revenue model (78%) facing guided high-teens % NII decline, VC-network transmission vector creating correlated withdrawal exposure. Market consensus (12B/11H/1S) framed as cyclical; analytical hygiene check on deposit trajectory (F3) reveals active deterioration not yet stabilized at Jan 31 2023 cutoff. Novel risk combination (rate rise + uninsured concentration + active outflow) distinguishes from prior VC downturns SVB survived. |by:product-strategist |weight:primary
  |ctx: SVB risk analysis r1, temporal boundary 2023-01-31, sources: FDIC call reports, Q4 2022 earnings release Jan 19 2023, CB Insights State of Venture 2022, Fed Evolution report (pre-cutoff data citations)
SVB interest rate risk assessment (as of Jan 31 2023): HTM unrealized loss ($15.1B) approaches full equity erosion visible in public Q4 2022 earnings data. NII sensitivity has structurally flipped from asset-sensitive to liability-sensitive — a reversal from +22.9% NII gain at +200bp (2021) to NII harm (2022). NIM declining from 2.28% peak to guided 1.75–1.85% for 2023. Fed rate trajectory (modal: 2–3 more hikes to ~5.25%) extends the adverse environment. VC funding winter (-35% YoY) mechanically drives NIB deposit outflows through same causal chain as rate hikes. Three simultaneous adverse effects (HTM losses, NIM compression, deposit attrition) share a common cause (Fed tightening) — no diversification benefit. EVE disclosure removed from 2022 10-K — the one metric that would have captured full equity impairment from long-duration fixed portfolio. Confidence: HIGH on data; MEDIUM on scenario probability weights. |by:macro-rates-analyst |weight:primary
  |ctx: SVB risk analysis r1 | temporal boundary 2023-01-31 | interest rate risk domain
SVB balance sheet risk assessment (r1, portfolio-analyst primary): The central risk signal visible from public Q4 2022 earnings data is the near-complete divergence between regulatory capital adequacy (~500bps CET1 headroom) and economic solvency (~$0.9B equity after HTM mark-to-market = 0.4% equity/assets). This divergence is entirely explained by GAAP HTM amortized-cost accounting plus AOCI opt-out — both legal and disclosed. Secondary risk: 94% uninsured deposits ($163.2B) vs $52.8B HQLA = 32% coverage ratio, with Q4 2022 FHLB drawdown ($13.6B new) confirming management was already managing deposit pressure at the Jan 31 2023 temporal boundary. The two risks are conditional on each other: regulatory capital holds only if deposits don't flee; deposits only flee if solvency concern materializes — a doom loop structure detectable from public filings. |by:portfolio-analyst |weight:primary
  |ctx: SVB risk analysis r1, temporal boundary 2023-01-31, sources: public filings only
SVB risk probability assessment (r1): P(significant adverse event, 12mo)=45-55% | P(failure/receivership, 12mo)=15-25% — 5-10x higher than market-implied P(failure) of <2-3%. Based on: (1) 94% uninsured deposits (top 1% US banks), (2) HTM unrealized losses at 94% of equity = near-insolvency on MTM, (3) 4 consecutive quarters of deposit outflows at 3.7x industry rate, (4) VC funding -35% YoY with no recovery catalyst, (5) wholesale funding surge $71M→$13.5B. Reference classes: Continental Illinois (100% distress, N=1), S&L crisis (32% failure, structural twin), WaMu/IndyMac (failure analogues). Pre-mortem: forced capital raise spiral (25-30%), slow bleed (20-25%), information cascade run (15-20%), rate rescue/survival (10-15%). All risk information was publicly available as of Jan 31, 2023. |by:reference-class-analyst |weight:primary
  |ctx: SVB risk analysis r1 — reference class forecasting and calibrated probability estimates using superforecasting methodology
regulatory-risk-assessment: SVB was 100% compliant with all applicable Category IV requirements (EGRRCPA 2018 + 2019 tailoring rules) as of Jan 31 2023. The dominant regulatory capital risk was structural: (1) HTM amortized-cost accounting placed $15.1B in unrealized losses completely outside CET1 computation by GAAP design — NOT an election, not the AOCI opt-out; the AOCI opt-out was minor ($2.5B, -165bps); the HTM gap was ~960bps delta vs reported 12.05% CET1. (2) No company-run stress test required since EGRRCPA 2018 — SVB never stress-tested the $91.3B HTM portfolio against +400bp scenario. (3) No LCR required through Jan 31 2023; 70% reduced LCR triggered by Dec 2022 STWF crossing but not yet effective. (4) No public IRRBB capital stress disclosure required. (5) One available public IRR capital signal: 2021 10-K EVE = -27.7% at +200bps — a rate shock already exceeded by +425bps as of cutoff. Governance: 8-month CRO vacancy April-October 2022 (publicly documented from press releases); no Risk Committee chair (2022 proxy); Kim Olson 27 days in role at cutoff. SVB was regulatory-clean from a compliance standpoint; the risk resided entirely in the gap between applicable requirements and economic reality. This is a compound regulatory-framework gap, not a compliance violation. |by:regulatory-licensing-specialist |weight:primary
  |ctx: SVB risk analysis as of 2023-01-31 | r1 regulatory framework assessment | sources: pre-cutoff public filings only
exit-gate: FAIL | r2 SVB risk analysis | engagement:B | unresolved:DA[#1](HTM-existential),DA[#2](zero-bull-case),DA[#3](P-failure-calibration),DA[#10](temporal-boundary) | untested-consensus:unanimous-bearish | hygiene:pass | R3 required before synthesis |by:devils-advocate |weight:primary
  |ctx: SVB risk analysis as of 2023-01-31 | 5 agents completed r1 with 26+ findings | zero bull case presented | zero dissent | all agents concluded high-risk | DA identified hindsight contamination as dominant bias vector | 10 challenges issued (4 material, 6 calibration) | exit-gate FAIL requires r3 bull-case engagement + calibration defense + temporal source-tagging
P(failure/receivership, 12mo) revised from 15-25% to 5-12% (point ~8%) after DA challenge | methodology: additive Bayesian updating from 0.14%/yr base rate | key factors: 94% uninsured deposits (strongest), HTM losses ~= equity (conditional on deposits), 4Q outflows, VC downturn, rate environment | 3-4x market divergence (vs 5-10x in R1) | honest calibration: R1 was ~2x overconfident due to outcome anchoring |by:reference-class-analyst |weight:primary
  |ctx: SVB risk analysis R3, responding to DA[#3] material challenge on probability calibration
DA-exit-gate:PASS(r3) |engagement:B+/A- |P(failure):revised 15-25%→5-12%(~8%),methodology-corrected,calibration-defensible |bull-case:engaged-by-4/4-responding-agents,genuine-not-cosmetic |temporal:DA[#10]-resolved,EVE-OUT-BOUNDARY,2-datapoints-removed |hindsight:acknowledged-finding-by-finding,~2x-overestimate-in-R1-calibration |consensus:elevated-risk-outlier(~8%),not-imminent-crisis,bull-case-live-Jan31 |grades:reg-lic=A,portfolio=A-,ref-class=B+(largest-improvement),prod-strat=B+,macro-rates=B(R3-absent) |team:B+/A- |noted-gaps:macro-rates-R3-absence(non-blocking,findings-factual),P(failure)-range-minor-discrepancy-PS-vs-RCA |→synthesis-ready |by:devils-advocate |weight:primary
  |ctx: SVB risk analysis review, 3-round ANALYZE mode. R2 exit-gate FAILED on 4 criteria (zero bull case, P(failure) uncalibrated, temporal leakage, untested consensus). R3 responses from 4/5 agents resolved all material challenges. Team demonstrated genuine analytical updating under DA pressure: P(failure) revised 2x downward, bull cases engaged at full strength, temporal boundary enforced, hindsight honestly assessed. Revised consensus is credible pre-cutoff analytical product.
SVB-risk-analysis(2023-01-31): P(failure)=5-12%(point~8%) after 3-round adversarial review | R1 overcalibrated at 15-25% due to hindsight contamination (~2x overestimate) | corrected via additive Bayesian replacing multiplicative adjustments | 3-4x market divergence defensible | key risk: 94% uninsured + near-zero economic equity + 4Q outflows = unprecedented combination | honest assessment: "elevated-risk outlier, not imminent crisis" | temporal boundary enforced 2023-01-31 |by:sigma-lead |weight:primary
  |ctx: First temporal-boundary financial institution risk analysis. DA exit-gate FAIL at R2 forced critical calibration revision. Team grade B+/A-.

## loan-admin-agent-tech-landscape R2 decisions (26.3.17)

DA-exit-gate:PASS(r2) |engagement:A(range A- to A+) |unresolved:none(3 tensions resolved) |untested-consensus:none |hygiene:pass |prompt-contamination:within-tolerance-with-flag(H3+H4 confirmatory) |→synthesis-ready |by:devils-advocate |weight:primary
  |ctx: 10 challenges issued against 5 agents' R1 findings. 3 pre-identified tensions all resolved. Key contributions: data integrity challenge (Hypercore headcount discrepancy), methodological challenge (Kroll settlement benchmark, H3 confirmation bias), gap identification (client-side adoption barriers). Team analytical quality HIGH — challenges calibration+verification ¬fundamental errors.

TENSION-1-resolved:timescale-reconciled |investment-urgency:18-36mo(loan-ops+tech-industry correct) |advantage-expectations:5-10yr(product-strategist correct) |market-share-shift:10-20yr(reference-class correct) |by:devils-advocate |weight:primary
  |ctx: not a disagreement but different horizons. All agents partially correct about different questions. Synthesis: act on 18-36mo cycle, expect results on 5-10yr, expect market share shifts on 10-20yr.

TENSION-2-resolved:H2-synthesis-adopted |"tech=floor¬ceiling"=product-strategist framing adopted |floor-is-rising(private-credit-growth) |"forces-adoption≠creates-winners" |by:devils-advocate |weight:primary
  |ctx: loan-ops recalibrate from "tech drives wins" to "tech prevents losses + marginal advantage." reference-class caveat elevated to headline.

TENSION-3-resolved:Hypercore-data-integrity-flagged |headcount:claimed-20,Y-Combinator-shows-7,Tracxn-shows-5 |all-metrics-self-reported |tech-architect-skepticism-most-warranted |by:devils-advocate |weight:primary
  |ctx: loan-ops uncritically accepted Hypercore Series A PR metrics. 75% fintech failure rate applies. No trust charter = regulatory ceiling. Downgrade from "extraordinary ops leverage" to "unverified ops claims."

Kroll-settlement-benchmark-corrected |use-8-vs-12(LSTA-Q2-2024-median)¬8-vs-47(Kroll-marketing) |33%-improvement¬83% |by:devils-advocate |weight:primary
  |ctx: "47-day market average" is Kroll's own website language, not LSTA data. LSTA Q2 2024 median par settlement = 12 days. Bloomberg #3 is separate claim from settlement speed claim — ¬conflate.

S&P-DataXchange-downgraded |monitoring-item¬landscape-changing-conclusion |zero-adoption-at-14-days-post-launch |5/5-unanimity=source-clustering-signal |by:devils-advocate |weight:primary
  |ctx: all agents identified DataXchange as most significant unexpected finding — unanimity itself suspicious. Analyst coverage explicitly flags adoption risk.

## sigma-audit verdict (26.3.17 | loan-admin-tech)

AUDIT-VERDICT:YELLOW→GREEN |review:loan-admin-agent-tech-landscape |date:26.3.17 |by:sigma-audit(independent-opus-agent)
  |initial: YELLOW(3 gaps: R2-responses-missing, CONTAMINATION-CHECK-absent, header-stale)
  |remediation: all 3 resolved — 21 DA responses(substantive), §6c-check(clean), header(post-r2)
  |re-audit: GREEN — all protocols pass, zero remaining issues
  |note: GREEN≠correct-findings. Run /sigma-evaluate for output quality.

AUDIT-FLAG[26.3.17]: R2-integration-skipped |remediation: agents wrote 21 responses |status:closed(remediated)

AUDIT-FLAG[26.3.17]: §2d-confidence-tiering-needed — [independent-research] covers company PR through SEC filings without distinction |remediation: add confidence qualifier to §2d |status:open(directive-update-pending)

## sigma-evaluate verdict (26.3.17 | loan-admin-tech)

EVAL-VERDICT:B(2.86/4.0) |review:loan-admin-agent-tech-landscape |date:26.3.17 |by:sigma-evaluate(3-evaluators+judge)
  |scores: scope-integrity=4, accuracy=3, completeness=3, logic=3, calibration=3, evidence=2, actionability=2
  |strengths: scope-discipline(4/4), reference-class-grounding(CAL6-highest-confidence), DA-challenge-quality(10/10-substantive)
  |weaknesses: evidence-quality(company-PR-as-independent-research), actionability(no-cost/timeline/kill-criteria), load-bearing-insights-buried(CAL2+CAL5)
  |improvements: §2d-three-tier-provenance, per-opportunity-scaffolding, elevate-CAL2+CAL5-to-headlines, demand-side-research-sprint

## warehouse-lms-game review — R3 verdicts (26.3.18)

verdict:DA#1-crowding-CONCEDE |by:product-strategist |weight:primary
  |ctx: game would NOT have been independent recommendation; Alt-C (embedded LMS decision-logging) wins on ecological validity; game justified only if C1 (low-barrier deploy) is hard requirement with explicit validity tradeoff

verdict:DA#2-pymetrics-analogy-DOWNGRADED |by:product-strategist |weight:primary
  |ctx: category error confirmed — construct/population/relationship/scenario all differ; Alt-C + Alt-D have stronger existing validation for this specific use case; Pymetrics = "directionally suggestive, not validating"

verdict:DA#4-discretion-audit=GATE |by:product-strategist |weight:primary
  |ctx: Thesis-C fails for fully-directed WMS operations at full scope; exception-scenario scoping (returns/cross-dock/batch) viable narrow alternative; audit must gate proceed/no-proceed

verdict:DA#5-EU-AI-Act-commercial-path-reduced |by:product-strategist |weight:primary
  |ctx: high-risk classification likely applies even under Thesis-C; conformity assessment+monitoring+worker-rep-consultation add $50-120K+ costs; internal deployment viable; commercial requires legal-review GATE

verdict:DA#8-governance=structural-not-policy |by:product-strategist |weight:primary
  |ctx: aggregate-only query enforcement + auto-deletion required at architecture layer; policy fails under organizational pressure; structural constraints = Thesis-C commitment made credible

## VDR competitive market analysis (26.3.18)

VDR-CAGR-scope-conditional |by:reference-class-analyst+economics-analyst+product-strategist |weight:primary(RCA)
  |ctx: VDR CAGR must be reported scope-conditional: pure-VDR 8-11%(IBISWorld-anchored), VDR+workflow 12-16%, VDR+broad-adjacent 18-22%. Single CAGR without scope definition = misleading. 2x analyst spread = scope noise not estimation noise.
  |DA-validated: yes(DA[1] resolved r3)

VDR-AI-two-tier-model |by:tech-architect+tech-industry-analyst+product-strategist |weight:primary(TA+TIA)
  |ctx: Tier-1 basic (OCR, redaction, NLP classification, summarization) = table stakes by 2027, premium collapses. Tier-2 advanced (proprietary training corpus, predictive analytics, agentic workflow) = differentiating 2028+, premium persists. Conflating tiers = wrong strategic response.
  |DA-validated: yes(DA[6] resolved r3)

VDR-platform-bifurcation |by:tech-industry-analyst |weight:primary
  |ctx: VDR market bifurcating into Deal-OS platform builders (Datasite, Midaxo, DealRoom) vs compliance-specialists (CapLinked, DFIN, SRS Acquiom). Middle-ground pure-VDR without platform expansion OR deep compliance specialization = commoditization trap by 2028.
  |DA-validated: yes(not directly challenged)

VDR-consolidation-through-acquisition |by:reference-class-analyst |weight:primary
  |ctx: VDR most probable future = consolidation-through-acquisition (ERP 2000s pattern) not disruption-by-innovation (Salesforce CRM pattern). Datasite/CapVest executing explicitly with $500M+. P(significant M&A consolidation, 3yr) = 75%.
  |DA-validated: yes(DA[2] partially resolved r3, RCA estimate validated over EA)

VDR-Datasite-leader-with-rollup-risk |by:reference-class-analyst+product-strategist |weight:primary(RCA)
  |ctx: Datasite is most likely market leader (base case) but carries 30% rollup failure probability. 8+ acquisitions since 2020, $113K rev/employee, FIS-Worldpay cautionary analogue. Must carry risk prominently, not bury in pre-mortem.
  |DA-validated: yes(DA[3] resolved r3, promoted from PM to primary finding)

VDR-per-page-pricing-structural-weakness |by:product-strategist+economics-analyst |weight:primary(PS)
  |ctx: per-page pricing ($0.35-0.85/page) generates 2-10x invoice overruns (SRS Acquiom 3,800-deal dataset). Creates buyer resentment, drives mid-market switching to flat-fee. Incumbents' Achilles heel. Per-page→subscription transition = 36% revenue compression short-term.
  |DA-validated: yes(cross-validated by all agents)

## workflow-automation-implementation r2 challenge (26.3.18)

challenge:success-rate-circularity |60-67%-from-self-interested-sources |survivorship-bias |must-distinguish-individual(55-65%)-vs-enterprise(20-35%) |by:devils-advocate |weight:primary
  |ctx: DA[#1]+DA[#2]. "Properly planned"=post-hoc tautology. RCA 27% joint prob=only honest treatment

challenge:premise-viability-untested |4-agents-accept-automation-without-testing-LSS/BPO/selective-manual |§2e-violation |by:devils-advocate |weight:primary
  |ctx: DA[#3]+DA[#6]. LSS 30-60% gains at lower cost. ANA5 lesson=process improvement PRECEDED automation

challenge:mid-market-evidence-gap |zero-quant-studies-300-1000 |all-extrapolated |vendor-cases-only-evidence |by:devils-advocate |weight:primary
  |ctx: DA[#5]+DA[#7]. UX-F11 hygiene:3=best self-flagging but buried

challenge:demand-side-absent+domain-conflation |cost-of-NOT-automating-unmodeled |70%-failure-from-adjacent-domains≠workflow-automation |by:devils-advocate |weight:advisory
  |ctx: DA[#4]+DA[#8]. Different domains conflated without adjustment

exit-gate:FAIL |unresolved:2 |untested-consensus:3 |by:devils-advocate |weight:primary
  |ctx: R3 must address: §2e, scope distinction, process improvement debate, operationalize "properly planned", vendor discounts

## workflow-automation-review R3 team decisions (26.3.18)

cost:TCO-model-required-not-license-only |by:tech-architect |weight:primary
  |ctx: T1-TCO=$38-112K/yr1, T2=$180-560K/yr1, T3=$600K-1.8M/yr1. License=15-30% of TCO. Presenting license-only figures misleads decision-makers, directly causes budget-exhaustion failure (RCA-PM6, 15-25% of failures). All deliverable cost figures must use TCO model with license clearly labeled as sub-component.
  |confidence: M (extrapolated from enterprise iPaaS, no mid-market-specific TCO study found)

analysis:individual-vs-enterprise-success-rates-must-be-distinguished |by:tech-architect+DA |weight:primary
  |ctx: individual-process=60% ROI within 12mo (vendor-aggregated, survivorship-biased, M-conf). Enterprise-wide=15-25% scale beyond pilot (M-H-conf, RCA-OV). 40-50pp gap IS the central finding. Every citation must specify scope or it is analytically dishonest. This was the root cause of the H1 framing disagreement (partially-confirmed vs partially-falsified = same substance, different scope definitions).
  |confidence: M-H

process:readiness-gate-precedes-tool-selection |by:tech-architect |weight:primary
  |ctx: TA-READINESS-SCORE (5 criteria, 1-day assessment) must gate the implementation guide. Score ≤3/5 → process improvement first (LSS/VSM, 8-16 weeks, $15-50K, 20-50% efficiency gain at 20-40% of automation cost). Score ≥4/5 → automation appropriate, proceed to tier selection. Combined approach dominates for ready organizations. Provides honest answer to DA §2e: automation is NOT unconditionally the highest-ROI approach for this segment.
  |confidence: M (derived from LSS + manufacturing analogues, not mid-market-specific)

## workflow-automation-review R4 exit-gate decisions (26.3.18)

exit-gate:PASS |by:devils-advocate |weight:primary
  |ctx: all 6 R3-must-address items genuinely addressed. Engagement A- to A across all 4 agents. Material analytical shift from automation-first to PI-first-conditional. No performative concession or relabeling evasion detected. New consensus (PI-first) stress-tested against R1 evidence (ANA5, DISCONFIRM) and PASSED. 1 minor unresolved: PS-F3 scalability figure (3:1-4:1 vs RCA 1.3:1-1.8:1, synthesis-resolvable). Synthesis can proceed.

framing:success-rate-primary-figures |by:devils-advocate(primary)+reference-class-analyst(primary) |weight:primary
  |ctx: individual-process:45-55%(RCA-calibrated,primary). Enterprise-wide:15-25%(all-converged). Guide must present BOTH with enterprise-wide as primary frame for implementation program context. PS and TA retain higher individual-process figures (55-65%, 60%) — use RCA's calibrated range as primary (survivorship-corrected), higher figures as upper-bound context.
  |confidence: M (all extrapolated, no mid-market-specific studies)

framing:PI-first-as-default-recommendation |by:all-4-agents+devils-advocate(stress-tested) |weight:primary
  |ctx: process-improvement-first for ~70-80% of 300-1000 segment. Automation conditional on readiness assessment passing threshold. Three readiness frameworks produced (TA-5pt, PS-18pt, UX-5pt) — synthesis must integrate into ONE unified assessment. PI-first consensus stress-tested by DA: grounded in R1 evidence (ANA5, DISCONFIRM), expanded with independent evidence in R3 — not herding under DA pressure.

framing:guide-title-and-structure |by:devils-advocate |weight:advisory
  |ctx: guide should be framed as "Operational Excellence" or "Workflow Optimization" not "Automation Implementation" per §2e consensus. Must open with readiness assessment gate, include mandatory limitations section (all evidence extrapolated, no mid-market validation, vendor case studies = marketing, readiness frameworks = unvalidated).

synthesis-note:PS-F3-scalability |by:devils-advocate |weight:advisory
  |ctx: PS-F3 scalability ratio (3:1-4:1 headcount:revenue) challenged by RCA (realistic: 1.3:1-1.8:1) and UX (work intensification equally plausible as role elevation). PS did not directly respond. Synthesis should use RCA's figure as realistic target, PS's as aspirational top-decile with explicit label. Not exit-gate blocking.

synthesis-note:readiness-framework-integration |by:devils-advocate |weight:advisory
  |ctx: three separate readiness frameworks (TA: 5-pt binary, PS: 18-pt scored, UX: 5-pt PR-scored) need integration into ONE unified assessment for the guide. Raw material sufficient — all three are ex-ante testable with specified methods and timelines. Honest admission: all are unvalidated against outcome data.
workflow-automation-review-complete |4-rounds(r1-research,r2-DA-FAIL,r3-response,r4-DA-PASS) |5-agents(TA,PS,UX,RCA,DA) |central-finding:process-improvement-first-for-70-80%-of-300-1000-segment,automation-conditional-on-readiness |success-rates-recalibrated:individual-45-55%(M),enterprise-15-25%(L-M) |deliverables:exec-summary+implementation-guide@~/Documents/ |key-shift:automation-first→PI-first-conditional(genuine-analytical-revision,¬performative) |all-evidence-extrapolated-from-general(zero-mid-market-specific-studies) |by:sigma-lead |weight:primary
  |ctx: workflow automation implementation analysis for 300-1000 employee companies, 2026-03-18

## biotech-healthcare AI M&A review — tech-industry-analyst decisions (26.3.18)

tech:AI-modality-maturity-bimodal |by:tech-industry-analyst |weight:primary
  |ctx: Radiology AI (1,356 FDA-cleared devices, Aidoc foundation model Jan 2026) = PRODUCTION-READY. Protein structure prediction = commoditized by end-2026 (AlphaFold3, Boltz-2, ESMFold all open). Small-molecule drug discovery AI = ACCELERATING (173 clinical programs, first Phase 3 expected 2026). Biologics/cell/gene therapy AI = still RESEARCH-STAGE. Longevity reversal drugs = MOSTLY HYPE (no Phase 2 data). Blanket "AI is transforming biotech" = analytically under-specified.

tech:structure-prediction-moat-gone |by:tech-industry-analyst |weight:primary
  |ctx: AlphaFold3 partially open-sourced; OpenFold3 community approaching parity; Boltz-2 (MIT+Recursion, Jun 2025) fully open, structure+binding affinity jointly, 1,000× faster than FEP, 200+ biotech adopters; ESMFold (Meta) 700M+ predictions free. New data moat = phenomics (Recursion 8yr head start), clinical outcome data (Epic-controlled), surgical recordings (Intuitive Surgical 10M+ procedures). Structure prediction ¬moat by end-2026.

tech:isomorphic-proprietary-model |by:tech-industry-analyst |weight:primary
  |ctx: Isomorphic Labs $600M raise Mar 2025 kept proprietary successor to AlphaFold3 (¬open-sourced unlike AlphaFold2/3). Strategy = vertical integration (foundation model → drug pipeline → IND-enabling studies). Targeting first clinical trials 2026-2027. NOT a platform licensor like Recursion. Distinct strategy from open-source ecosystem.

tech:NVIDIA-infra-layer-not-biotech-acquirer |by:tech-industry-analyst |weight:primary
  |ctx: NVIDIA positioned as compute infrastructure layer (BioNeMo, $1B Eli Lilly partnership Jan 2026, Novo Nordisk Gefion supercomputer Jun 2025). Analogy to Zebra+Fetch infrastructure acquisition (P[26.3.14]) = more likely to acquire biotech-specific AI infrastructure tools (data management, workflow orchestration) ¬drug assets ¬pharmaceutical companies. OpenAI ¬primary drug discovery actor.

tech:GLP-1-platform-molecule-disruption-risk |by:tech-industry-analyst |weight:advisory
  |ctx: TIA-10 D4. Emerging evidence GLP-1 agonists reduce Alzheimer's risk + cardiovascular events + addiction (non-metabolic indications). If Phase 3 trials confirm, GLP-1 becomes platform molecule → massive revaluation + new M&A wave in CNS/cardio for GLP-1 combos. HIGHEST PROBABILITY disruption not captured in standard M&A frameworks. Current deal analysis focused only on metabolic/obesity angle.

tech:AI-Phase3-failure-material-downside |by:tech-industry-analyst |weight:advisory
  |ctx: TIA-10 D6. First AI-discovered drugs expected to hit Phase 3 in 2026. If they fail, AI-biotech narrative deflates → platform acquisitions repriced → capital exits AI-biotech. Current analyst frameworks price in success scenario. Failure scenario = MATERIAL DOWNSIDE RISK to H1 (AI creating significant M&A opportunities). Flag for DA priority challenge.

tech:H4-partially-falsified |by:tech-industry-analyst |weight:primary
  |ctx: H4 (AI as net M&A catalyst vs enabling organic build) = PARTIALLY FALSIFIED. Mega-pharma is BOTH building internally (Lilly TuneLab Sep 2025, $1B NVIDIA AI factory; Novo Nordisk Gefion sovereign supercomputer Jun 2025) AND acquiring AI-native startups. Answer is SPLIT by company size: mid/small pharma = acquisition primary; mega-pharma = hybrid (build+partner+acquire). ¬universal net M&A catalyst direction.

## biotech-healthcare AI M&A review — DA r2 challenge decisions (26.3.18)

challenge:H1-divergence-is-central-unresolved-question |PS:CONFIRMED(AI=primary-catalyst) vs RCA:ADDITIVE(cliff+rates=80%+-regardless) |both-cannot-be-synthesis-conclusion |R3-must-reconcile-or-split-with-probabilities |by:devils-advocate |weight:primary
  |ctx: DA[#1]. This is the CENTRAL question of the review. PS treats AI as the engine driving M&A. RCA treats AI as flavor added to structurally-driven M&A. External evidence supports RCA: CNBC Jan 2026 "big pharma race to snap up biotech assets as $170B patent cliff looms" — headline is cliff ¬AI. AlphaSense, ING, PwC all cite patent cliff+rates as PRIMARY. AI = secondary/emerging

challenge:AI-premium-unmodeled-correction-risk |Recursion-33-41x-vs-sector-10-11x-but-0-FDA-approvals+REC-994-discontinued+BenevolentAI-delisted |Dalio-"80%-euphoria"+Altman-"overexcited"+AI=50%-all-VC-2025 |premium-compression-30-50%-unmodeled |by:devils-advocate |weight:primary
  |ctx: DA[#2]. PA-F4 documents premium but not sustainability. AI sector concentration at 50yr high. If correction occurs, deal economics change materially. Must model compressed-premium scenario for synthesis

challenge:post-acquisition-integration-failure-unaddressed |pharma-MA-integration-40-60%-value-destruction-rate+Watson-$5B→$1B(80%-loss)+AI-adds-complexity(talent-retention,data-systems,culture) |$240B-deals=$96-144B-potential-destruction-at-base-rate |by:devils-advocate |weight:primary
  |ctx: DA[#4]. Zero agents modeled post-acquisition outcomes. Approval of deals ¬ success of deals. Synthesis that projects M&A volume without integration risk = incomplete

challenge:adoption-gap-undermines-AI-premium-thesis |1,356-FDA-cleared-devices+73%-clinician-override+30%-non-use+91%-integration-difficulty |approved-¬adopted-¬value-creating |by:devils-advocate |weight:primary
  |ctx: DA[#5]. If AI assets don't translate to clinical adoption, acquirer ROI disappoints, premiums compress. This is the mechanism by which AI premium correction could occur. Links DA[#2] to DA[#5]

assessment:exit-gate-FAIL |engagement:B+(range-B+-to-A) |unresolved:H1-divergence+AI-premium-sustainability |untested-consensus:H3-unanimous+AI-catalyst-framing |hygiene:pass-with-flags |prompt-contamination:within-tolerance |by:devils-advocate |weight:primary
  |ctx: R3-MUST: (1)H1 reconciliation PS vs RCA, (2)AI premium compression modeling, (3)post-acquisition integration risk, (4)173-programs phase decomposition, (5)§2e premise checks by PS+PA

assessment:RCA-best-calibrated-synthesis-must-anchor |additive-¬primary|Watson-disconfirmation|calibrated-CIs|outside-view-reconciliation |synthesis-that-contradicts-RCA-without-explanation=analytically-dishonest |by:devils-advocate |weight:advisory
  |ctx: DA[#12]. RCA = only agent that ran disconfirmation duty, provided calibrated probabilities with CIs, and identified that inside-view overstates AI causal role

## biotech-healthcare AI M&A review — RCA r3 DA-response decisions (26.3.18)

H1-reconciliation:AI-as-Structural-Accelerant(3-category-framework) |AI-irrelevant=55-65%|AI-additive=20-30%|AI-primary=8-15%→20-25%-by-2031 |PS-RCA-CONVERGENT("deal-shaper-¬deal-engine") |by:reference-class-analyst+product-strategist |weight:primary
  |ctx: DA[#1] CRITICAL. PS R1=CONFIRMED, RCA R1=ADDITIVE. R3: PS conceded PARTIALLY CONFIRMED + "deal-shaper ¬deal-engine." RCA proposed quantified 3-category framework. CONVERGENCE achieved. Structural forces (cliff+rates+firepower) drive 55-65%. AI grows ~10%→20-25% by 2031 but never dominates

173-decomposition:M&A-relevant=28-34(Phase2+)=16-20%-of-173 |expected-FDA-AI-drugs-by-2031:4-8(optimistic)/2-5(base-rate) |by:reference-class-analyst |weight:primary
  |ctx: DA[#5]. Phase breakdown: ~40 P1, ~26-31 P2, 2-3 P3, 0 NDA. Base rates: P1→P2=47%, P2→P3=28%, P3→NDA=55%, LOA=6.7%. AI P1 claimed 80-90% vendor-forward → blended 63%. "173 programs" anchor deflated to ~28-34 M&A-relevant

Eroom's-compositional-assessment:~50%-compositional+~50%-real|reversal-UNDEMONSTRATED |AI-R&D-productivity-~50%-overstated-vs-inside-view |by:reference-class-analyst |weight:primary
  |ctx: DA[#3]. 85% accelerated approval=oncology, 57% failed confirmatory trials, P3 required 26% AA vs 75% regular. Real component: ROI 1.2→5.9%, biomarker stratification. Net: market pricing AI reversal; evidence = partial deceleration partially artifactual. STRENGTHENS RCA R1

AI-healthcare-failure-catalogue:N≥5/$14B+-systematic-pattern |Watson+Olive+Babylon+Pear+BenevolentAI |ANA[5]-ELEVATED |PM[2]=20-25% |by:reference-class-analyst |weight:primary
  |ctx: DA[#8]. Watson NOT N=1 outlier. Extended: Olive($4B→$0), Babylon($4.2B→$0), Pear(→$6M), BenevolentAI(delisted). Pattern: marketing>capability, ambitious scope, data quality underestimated, adoption assumed. Healthcare 0.8%→2.8% of ALL startup shutdowns

CAL-revisions-R3:H1=72→68%|H1a=55→50%|H4=62→60%|PM[2]=15-20→20-25%|H2,H3-unchanged |by:reference-class-analyst |weight:primary
  |ctx: net modest-downward. DA challenges STRENGTHENED RCA R1 position on 3/4 items (Eroom's compositional, failure catalogue, 173 decomposition). Only H1-reconciliation was compromise ¬ concession

## biotech-healthcare AI M&A review — DA r3 exit-gate decisions (26.3.18)

exit-gate:R3-PASS |by:devils-advocate |weight:primary
  |ctx: R2 exit-gate FAIL had 2 critical issues: (1) H1 divergence PS-vs-RCA, (2) AI premium compression unmodeled. Both resolved in R3. PS conceded H1 to PARTIALLY CONFIRMED. PA modeled 40%/60% compression scenarios. RCA proposed 3-category framework. All 10 DA challenges resolved (8 direct, 2 by proxy)
  |decision: synthesis authorized. R3 quality exceeds R1 across responding agents. DA pressure materially improved review analytical quality

assessment:R3-agent-grades |by:devils-advocate |weight:primary
  |ctx: PS(B+→A-: H1 concession+§2e+sector gap-fill), PA(B+→A: compression modeling+integration risk+volume/premium separation=best R3 contribution), RCA(A maintained: framework+Eroom's compositional+failure catalogue)
  |decision: all 3 responding agents engaged substantively with new evidence ¬restated R1. Engagement quality ≥ A- across all. TIA/EA/RA maintained R1 grades (¬responded R3)

stress-test:new-consensus-survives |by:devils-advocate |weight:primary
  |ctx: "AI as Structural Accelerant" 3-category framework stress-tested on 5 dimensions: (1) category boundary fuzziness=valid-concern-¬undermining, (2) RCA probability revisions=modest-but-honest-¬performative, (3) volume/premium separation=valid-with-caveat(floor=$180-220B-¬$240B), (4) convergence asymmetry=genuine(PS-moved-more-than-RCA=appropriate), (5) label-vs-substance=acceptable-if-synthesis-presents-quantified-breakdown
  |decision: new consensus survives stress-test. 2 minor caveats for synthesis: volume floor $180-220B, present 3-category quantification ¬just label

synthesis-guidance:volume-vs-premium-separation |by:devils-advocate |weight:directive
  |ctx: PA R3 §2e identified: review conflated "M&A happening" (robust, cliff-driven) with "AI premiums sustainable" (fragile, Phase-3-contingent). These are ¬equivalent claims
  |decision: synthesis MUST present these as separate theses. M&A VOLUME thesis = HIGH CONFIDENCE. AI PREMIUM thesis = CONDITIONAL. Conflating them misrepresents the evidence base
meta-review-H1:UNCONFIRMED|structural-mechanisms-real(context-firewall,persistent-calibration)|net-quality-vs-cost-unmeasured|CAL-H1=45%|80%CI[28%,62%]|Google/MIT:multi-agent-degrades-sequential-39-70%|MAD:debate≈voting|→controlled-comparison-designed(DC-market-topic)|26.3.19 |by:sigma-lead |weight:primary
  |ctx: meta-review of sigma-review system — 4 agents + DA, 3 rounds, exit-gate PASS
meta-review-H4:NOT-PLATFORM-QUALITY|sigma-mem-blocks(1175L-handlers-SRP,0%-server-cov)|hateoas-agent=platform-quality(91%cov,typed,zero-deps)|infra=partial|CAL-H4=8%|addressable-users=100-500(¬10K-50K)|P(fail-3yr)=75-85%|→do-NOT-pursue-platformization|26.3.19 |by:sigma-lead |weight:primary
  |ctx: meta-review — all agents converged after DA challenge
build-mode-spinoff:COMPLETE|/sigma-build skill created(262L)|build-directives.md created(257L)|directives.md→ANALYZE-only|DA-agent-updated(cross-ref both)|¬content-lost→moved+cross-referenced|26.3.19 |by:sigma-lead |weight:primary
  |ctx: user decision to separate BUILD into own skill for independent curation
H1-power-binding: PARTIALLY CONFIRMED with multi-constraint model — power binds regionally (PJM/ERCOT); labor binds construction nationally; chips create global ceiling; community opposition creates political ceiling; tariffs create cost ceiling. No single constraint is "the" constraint |proposed-reconciliation: all agents adopt multi-constraint framing |by:devils-advocate |weight:primary
  |ctx: DA[#6] challenge — TA rated H1 CONFIRMED, EMA/RCA rated PARTIAL. Independent research confirms power is A constraint not THE constraint. Labor (439K shortage), chips (36-52wk GPU lead, 70% global memory to DC), community opposition ($64B blocked, 12 states moratorium bills), tariffs (+16% cost) all co-bind
H4-nuclear: SPLIT VERDICT — restart-CONFIRMED(TMI/Clinton/Susquehanna, ~4GW by 2030, credible) | new-build/SMR-DISCONFIRMED for 2026-2030(P≤10%, zero operating SMRs, NuScale cancelled then restarted for 2032, reference class devastating) |proposed-reconciliation: EMA+RCA adopt two-part verdict |by:devils-advocate |weight:primary
  |ctx: DA[#7] challenge — EMA CONDITIONAL-CONFIRMED conflates two structurally different nuclear paths. RCA DISCONFIRMED(P=5%) doesn't credit restart deals. Resolution separates restart (credible, near-term) from new-build/SMR (reference-class-devastating, 2032+ at best)
exit-gate:PASS(r3)|US-DC-infrastructure-constraints|engagement:[TA:A,EMA:A-,PS:A,RCA:A]|challenges:10/10-held|unresolved:none-material(deliberate-divergence:EMA-restart-P=35-50%-vs-RCA-P=70%)|untested-consensus:none(4-tested)|hygiene:pass|prompt-contamination:pass|→SYNTHESIZE |by:devils-advocate |weight:primary
  |ctx: r3-exit-gate|4-agents(TA,EMA,PS,RCA)|10-DA-challenges-all-held|R1-had-significant-gaps(labor,tariffs,chips,demand-side)|R3-corrected-all-with-independent-evidence|multi-constraint-model-replaces-power-as-sole-constraint|H4-divergence-resolved-via-bifurcation|analysis-now-investigative-¬confirmatory|synthesis-ready
tiered-methodology-architecture:APPROVED|Tier1=structured-single-instance(orchestrator-workshops-prompt,~50-100K-tokens,~24-25/30)|Tier2=lean-review(research+DA,~200-400K-tokens,~26-27/30,UNTESTED-needs-comparison)|Tier3=full-sigma-review(current-process-with-gaps-fixed,~1.5-2M-tokens,28/30,PROVEN)|Tier4=multi-model(Claude+GPT+Gemini,genuine-diversity,FUTURE-engineering-project)|build-order:validate-T1-prompt→test-T2-comparison→fix-T3-gaps→explore-T4|orchestrator-workshop=load-bearing(prompt-quality-determines-T1-value)|tier-inflation-risk:orchestrator-must-push-DOWN|evidence:controlled-comparison-28vs24-scored-by-ChatGPT-blind(30-40x-cost-for-17%-improvement)|26.3.19 |by:sigma-lead |weight:primary
  |ctx: meta-review + controlled comparison: single-instance vs sigma-review on US DC market analysis, blind-evaluated by ChatGPT
cognitive-frameworks-for-sigma-review: P=30% improve ALL dimensions, higher for SPECIFIC dimensions | highest-value interventions ranked: (1)formal-Brier/log-scoring-on-resolvable-estimates (2)metacognitive-self-challenge-in-r1-before-DA (3)accuracy-weighted-prediction-tournament-across-agents | ¬recommended: extremization(harmful-for-small-expert-teams), heavy-CFF-additions(framework-theater-risk-30-35%) | accuracy-tie-requires-fact-verification-step¬more-calibration-frameworks |by:reference-class-analyst |weight:primary
  |ctx: cognitive-enhancement-meta-analysis-r1 | addresses Q2,Q3,Q5,Q6,H1,H3,H5 | base-rate-grounded
framework-implementation-priority: CQoT-exit-gate-hardening + calibration-as-protocol = highest-ratio-implementations (prompt-level, zero architecture change, combined effort = minimal). Second tier: metacognitive-self-challenge-in-r1 (formalizes existing zero-dissent CB). Deferred: ACH (implement selectively when ≥3 competing hypotheses). Avoided: TEC standalone (high effort, conceptual value absorbed by ACH), per-review Brier Scores (retrospective, ≤40% resolvable estimates). Decision driver: §2c cost audit reversed initial intuition ranking. Highest unlisted framework = RTBT (proactive adversarialism) + Layered-CoT (addresses accuracy tie via intermediate validation). |by:product-strategist |weight:primary
  |ctx: meta-analysis of cognitive enhancement frameworks for sigma-review — r1 research round
TEC/ECHO coherence map: AVOID for sigma-review. DA exit-gate already performs coherence enforcement. No evidence of DA failure at coherence across 8+ reviews. Cost: +15-20% overhead + synthesis-validator agent for unclear marginal value. If evidence of DA coherence failure emerges in future review, revisit. |src:cognitive-enhancement-review|26.3.21|§2c-outcome-1-changed-analysis |by:tech-architect |weight:primary
  |ctx: Evaluating TEC/ECHO implementation within sigma-review's existing architecture. Decision driven by cost audit (§2c) + DA architecture overlap analysis.
FORMAT-vs-COGNITIVE-transfer-distinction: cognitive frameworks transfer to LLMs ONLY at FORMAT/COMPUTATIONAL level (85% confidence). Frameworks requiring cognitive skills (metacognition, diagnosticity assessment, error self-detection) show weak transfer (35%). All framework recommendations must be weighted by transfer mechanism type. This is the decisive filter for framework selection. |by:cognitive-decision-scientist |weight:primary
  |ctx: cognitive-enhancement-meta-analysis 26.3.21 | based on: Nature Reviews Psychology 2025 (dual-process in LLMs), Dhami 2019 (ACH diagnosticity failure), arxiv:2508.06225 (LLM overconfidence), Steyvers & Peters 2025 (implicit>explicit confidence) | addresses Q3, H3
Dialectical-Bootstrapping = highest-ROI cognitive enhancement for sigma-review: zero additional agent cost, 75% empirical success rate (Herzog & Hertwig 2009), FORMAT-level transfer (high), directly targets herding (worst failure mode). Formalizes "metacognitive self-challenge in R1" with specific protocol: estimate → assume wrong → reasons → re-estimate → reconcile. IS the empirically-grounded version of PS-F1 #3. |by:cognitive-decision-scientist |weight:primary
  |ctx: cognitive-enhancement-meta-analysis 26.3.21 | addresses Q4, Q5, H2 | cross-validates PS-F1 #3 metacognitive-self-challenge
DA-as-dialectical-condition (Mercier & Sperber mechanism): DA's irreducible value is DEEPER than adversarial checking — it creates the structural condition (dialectical context) under which individually biased argumentative reasoning becomes collectively truth-tracking. This explains: DA-challenges-spark-superior-findings, R1 herding (no dialectical context), and MAD-without-DA failures. DA is not optional enhancement — it is the cognitive architecture enabling truth-tracking. |by:cognitive-decision-scientist |weight:primary
  |ctx: cognitive-enhancement-meta-analysis 26.3.21 | Mercier & Sperber 2011 argumentative theory of reasoning | addresses team pattern: irreducible-multi-agent-value, DA-challenges-spark-superior-findings
exit-gate:FAIL(r2) — cognitive-enhancement-meta-review requires R3 to address: (1)faculty-mapping-disagreement-CDS-vs-TA (2)CQoT-marginal-value-demonstration (3)accuracy-error-classification (4)dialectical-bootstrapping-transfer-taxonomy (5)self-reference-acknowledgment (6)CQoT-prompt-echo-resolution |by:devils-advocate |weight:primary
  |ctx: R2 challenge round for cognitive enhancement meta-review. 10 challenges delivered. 3 untested consensus items, 2 material disagreements unresolved. Prompt audit: mixed methodology with CQoT echo cluster.
REVISED-PRIMARY-RECOMMENDATION: enhanced single-instance with superforecasting protocol + CQoT + metacognitive self-challenge = primary recommendation for tasks NOT meeting 3-condition ecological boundary. Full sigma-review RESERVED for: (1) stakes ≥$1M OR regulatory exposure OR ≥12mo product strategy AND (2) herding-risk question (comfortable consensus answer) AND (3) calibration-mattering (decision-maker acts differently at P=40% vs P=70%). Falsification conditions for sigma-review ecological justification: fact-verification-resolvable questions | same-domain-low-accuracy history | functional-diversity-zero domain. This reverses R1 emphasis from framework-addition to cost-reduction as primary. |src:PS-R3-DA[#9]+DA[#5]+PS-F2 |confidence:MODERATE(N=1-rubric-anchoring-acknowledged) |requires-sigma-audit-validation |by:product-strategist |weight:advisory
  |ctx: cognitive-enhancement-meta-review R3 DA responses — DA[#9] forced surfacing of suppressed cost-reduction recommendation
Attention faculty rating is level-dependent: mechanism=WEAK (LLM has no architectural selective attention, uniform salience weighting), behavioral-outcome=MODERATE (round-structure+§7-decomposition compensate). For recommendations, mechanism-level is operationally more important — compensations can fail under prompt-load or time pressure. Deliberate divergence between CDS(WEAK) and TA(WEAK-MODERATE) is evidential not disagreement — both correct descriptions of different levels. |by:tech-architect |weight:primary
  |ctx: cognitive-enhancement meta-review R3, resolving CDS vs TA Attention faculty rating disagreement, 26.3.21

## sigma-audit: kaggle-agi-benchmark (26.3.23)

AUDIT-FLAG[26.3.23]: CB-hard-gate-violated — lead advanced R1→R2 without firing zero-dissent circuit breaker despite DA documenting zero divergence across 5 agents on 4 major claims |remediation:lead must implement CB hard gate check before R2 advancement |status:closed(process-gap-analytically-compensated:DA-R2-herding-challenges-produced-genuine-revisions—PS-EF→Metacog-concession,CDS-72%→62%,RCA-Lake-Wobegon-correction;forward-fix-logged-in-patterns)
AUDIT-FLAG[26.3.23]: §2d+-quality-tiers-skipped — zero T1/T2/T3 tags on any finding including load-bearing (CDS P=72%→62%, RCA P(baselines)=72%, contamination claims) |remediation:all agents must tag load-bearing findings with quality tiers |status:closed(retroactive-tier-audit-added-to-workspace-26.3.23)
AUDIT-FLAG[26.3.23]: §2f-hypothesis-matrix-skipped — 6 hypotheses met ≥3 threshold but structured matrix not populated; agents assessed narratively instead |remediation:lead must populate matrix at R1 convergence |status:closed(matrix-compiled-from-agent-findings-added-to-workspace-26.3.23)
AUDIT-FLAG[26.3.23]: §2g-dialectical-bootstrapping-skipped — zero DB[] entries; agents wrote findings directly without self-challenge |remediation:lead must verify DB[] presence before declaring R1 convergence |status:closed(process-gap-analytically-compensated:DA-R2-forced-equivalent-self-revision—PS-track-switch,CDS-P-revised-10pp,RCA-P-revised-upward;forward-fix-logged-in-patterns)
AUDIT-FLAG[26.3.23]: §6-contamination-check-missing — no formal CONTAMINATION-CHECK section in workspace; DA-F5 performed prompt audit function but not labeled per §6 |remediation:add explicit section to workspace template |status:closed(formal-contamination-check-section-added-to-workspace-26.3.23)
AUDIT-VERDICT[26.3.23|kaggle-agi-benchmark]: YELLOW→GREEN |5/5-flags-closed(3-remediated,2-analytically-compensated) |DA-performance-strong(80%-hold,XVERIFY-deployed) |source-provenance-clean(0%-untagged,1%-prompt-claim) |source-quality-strong(10/15-load-bearing=T1,0-T3) |analytical-quality-high |forward-fixes:CB-hard-gate+DB[]-verification-logged-in-team-patterns |by:sigma-audit


## hateoas-agent improvement review (26.3.25)

forecast:adoption-base-rate-2-5% |by:reference-class-analyst |weight:primary
  |ctx: RC1(small single-author PyPI packages), RC2(AI agent tooling 2024-2026), RC4(market consolidation). GitHub: 0 stars, 0 forks, 17 days old, not on PyPI
  |evidence: 5/5 successful analogues (Instructor, Rich, Typer, httpx, Pydantic) required distribution + quality, 0/5 succeeded on quality alone
  |decision: base rate for >50 stars + >1K monthly downloads within 12mo = 2-5% | code improvements move to 5-8% | code + distribution = 12-30%

forecast:distribution-is-binding-constraint |by:reference-class-analyst |weight:primary
  |ctx: library already A-/A grade (review-7, reconfirmed this review). Inside-view assumes quality→adoption; outside-view says distribution is the variable that moves probability
  |evidence: ANA-pattern 5/5, PM1 "nobody came" is 35-40% probability scenario, OV-RECONCILIATION shows inside-view ~30% correct on whether improvements alone drive adoption
  |decision: code improvements = adoption readiness prerequisites ¬adoption drivers. Binding constraint is distribution (content marketing, ecosystem integration, PyPI publish)

forecast:plugin-strategy-over-framework-strategy |by:reference-class-analyst |weight:primary
  |ctx: AI agent framework consolidating to 5-7 leaders. LangGraph 24.8K stars, VC-backed. AutoGen maintenance mode. Single-author standalone frameworks: <1% reach top-20
  |evidence: Instructor pattern (thin composable layer ON existing tools), framework absorption risk 25-35% within 18mo
  |decision: viable path is niche-excellence or plugin-for-existing-frameworks ¬standalone framework competitor. Plugin strategy 3-5x higher adoption P than standalone

DA:README-accuracy-before-features |by:devils-advocate |weight:primary
  |ctx: README comparison table claims "Model dependency: Any" — Runner requires anthropic. Install instructions reference nonexistent PyPI. URL uses coloradored13 not bjgilbert. No R1 agent caught specific false competitive claim.
  |decision: README factual accuracy MUST be corrected before any feature work. False competitive claims erode trust on first contact.

DA:code-vs-distribution-priority |by:devils-advocate(incorporating RCA) |weight:primary
  |ctx: 5/6 agents code-focused. RCA: code-only=2→5-8% adoption, code+distribution=12-30%. PyPI+README=both code AND distribution.
  |decision: Priority: (1)PyPI publish+README accuracy, (2)guard observability(F-UX1), (3)distribution activities, (4)remaining code fixes. Code improvements=prerequisites ¬drivers.

DA:exit-gate-FAIL-r2 |by:devils-advocate |weight:gate
  |ctx: engagement PASS(all B+). Unresolved: README false claims, code-vs-distribution, PyPI delay. Untested: code-priority consensus. Hygiene: §2d 0/6, §2e absent.
  |decision: R3 required. Must address: README accuracy, code-vs-distribution reconciliation, §2d compliance, PyPI blocker investigation.
AUDIT-FLAG[26.3.25]: §2d+ source quality tiers — zero compliance across 6 agents + DA missed. Load-bearing findings (TA-F1, PS-F2, PS-F4, RCA-CAL1-5) lack tier tags |remediation:retroactive-tier-tagging(15min) |status:open |by:sigma-audit |weight:primary
  |ctx: hateoas-agent improvement evaluation audit 26.3.25
AUDIT-REMEDIATED[26.3.25]: hateoas-improvement audit YELLOW→remediated | §2d+ tier tags added to all load-bearing findings | CONTAMINATION-CHECK added to workspace | agent template updated (§2d examples+enforcement) | DA checklist updated (§2d+ as explicit criterion 4a/4b) | §2g scoping clarified (required for probabilistic, optional for deterministic) |status:closed |by:sigma-audit |weight:primary
  |ctx: remediation of AUDIT-FLAG[26.3.25] after sigma-audit YELLOW verdict
RWI-escrow association: RWI-identified deals associated with median general indemnification escrow of 0.35% of TV vs 10.0% for non-identified deals (2024 SRSA data). Causation cannot be established from closed-deal data (buyers don't always disclose RWI; sample contamination both directions). Association confirmed by XVERIFY partial (both openai+google). Framing must use "associated with" not "RWI substitutes for" — the mechanism is consistent with RWI absorbing coverage function but data cannot prove it. |by:loan-ops-tech-specialist |weight:high — directly supported by XVERIFY cross-verification (partial) and consistent across 4+ slides
  |ctx: Private M&A deal terms analysis, SRSA 2025 study, slides 80-84. Relevant to all cap, escrow, and basket analyses where RWI segmentation is used.
Earnout buyer-covenant asymmetry: In 2024, buyers successfully resist affirmative earnout covenants (CRE at 10%, past-practices at 3%) while sellers are largely limited to the non-interference covenant (90%). This structural asymmetry means revenue-metric earnouts operate without buyer obligation to maximize revenue, making earnout achievement dependent on buyer good faith and non-interference protection rather than affirmative buyer cooperation. Implication: revenue earnouts are weaker seller protection than they appear — the absence of CRE/past-practices covenants is a significant buyer win in 2024 data. |by:loan-ops-tech-specialist |weight:high — directly supported by slide 27 data, important for synthesis framing
  |ctx: Private M&A deal terms analysis, SRSA 2025 study slides 25-27. Relevant to earnout analysis and any buyer/seller negotiating position recommendations on earnout structure.
RWI bifurcation is mandatory for all financial deal terms — any analysis presenting single "market standard" for caps, escrows, baskets, sandbagging, or survival without RWI/no-RWI segmentation is methodologically incomplete. Financial terms show 2x-28x outcome differences by RWI status. |by:reference-class-analyst |weight:primary — reference class calibration is core expertise
  |ctx: SRSA 2025 Deal Terms Study analysis, H1 test, cross-verified by GPT-5.4 (partial) and Gemini-3.1-pro (agree)
Closed-deal outcome frequencies must NOT be presented as achievability rates for negotiation planning. The data shows where negotiations ended, not what outcomes were possible. Correct framing: "X% of closed deals contained this term" rather than "X% chance of achieving this term." |by:reference-class-analyst |weight:primary — forecasting methodology is core expertise
  |ctx: SRSA 2025 Deal Terms Study analysis, DISCONFIRM[3], methodological caution for all peer agents
NET MARKET DIRECTION (2024 private-target M&A): MIXED with structural buyer advantage on economics. Legal/indemnification terms moved seller-favorable (shorter survival, more walk-away deals, shorter earnouts, termination fee recovery). Economics/valuation moved buyer-favorable (2.5x median return vs 5.2x in 2021 = 52% compression; rising seller hold periods = exit pressure). These vectors run in opposite directions. The multiple compression loses full turns of value; legal term improvements recover basis points. Calibrated formulation: "mixed market with structural buyer advantage on economics, seller gains on legal mechanics." XVERIFY: Gemini DISAGREE on blanket seller-favorable framing (high confidence); GPT-4 PARTIAL. Both models pushed back on causal overreach. |by:product-strategist |weight:high — primary source data (T1), XVERIFY-calibrated, DB[] applied to 3 findings
  |ctx: SRSA 2025 Deal Terms Study, 2,200+ private-target deals, $505B aggregate, 2019-2024. Slides 7-18, 94-99. XVERIFY run on 2 load-bearing findings.
TD-1: RWI DRIVES LARGEST LEGAL TERM SHIFTS — The 36-point differential in general rep survival (82% survival in non-RWI deals vs 46% in RWI deals) is the single largest RWI-driven term shift across all legal deal terms. In 2024, 54% of RWI-identified deals have no survival of general reps and warranties — a majority outcome for the first time (up from 37% in 2021). PRECISION: "no survival" applies to general reps only; seller retains exposure for fundamental reps (taxes, cap, org, authority, ownership, broker fees), fraud carveouts, and specific stand-alone indemnities in both survival and no-survival structures. |by:m-and-a-deal-counsel |weight:HIGH
  |ctx: SRSA 2025 Deal Terms Study, slide 57. XVERIFY-PARTIAL: data confirmed; scope narrowed to general reps per GPT-5.4 review. Weight: HIGH (load-bearing finding for indemnification structure analysis).
TD-2: FRAUD DEFINITION STAKES INVERTED IN RWI NO-SURVIVAL DEALS — In RWI deals with no survival of general reps (54% of RWI deals in 2024), fraud is seller's PRIMARY remaining personal exposure category. The stakes of the fraud definition negotiation are HIGHER in RWI no-survival deals than in non-RWI deals — the opposite of intuition. Sellers in RWI deals should prioritize narrow fraud definitions ("actual fraud" 35%, "intentional fraud" 47%, Delaware law definition 25%). Buyers in RWI deals should resist the Delaware law limitation on fraud definition. "Actual fraud" definition surged from 24% (2023) to 35% (2024) — MOVING SELLER-FAVORABLE. |by:m-and-a-deal-counsel |weight:HIGH
  |ctx: SRSA 2025 Deal Terms Study, slides 87-88. Derived finding (DB[4] dialectical bootstrapping). Weight: HIGH (counterintuitive finding with significant practical implications for RWI deal structuring).
TD-3: MATERIALITY SCRAPE PARADOX — RWI DEALS SHOW LOWER INCLUSION (80.4% vs 88.8%) BUT HIGHER AGGRESSIVENESS (69.1% vs 55.1% breach+damages form). XVERIFY-AGREE (high confidence on data). Hypothesis: the 80.4% RWI rate is diluted by the 54% of RWI deals that have no survival of general reps, making the scrape moot in those deals. Among survival-only RWI deals, scrape inclusion is likely much higher and breach+damages form dominates because RWI insurers need certainty on the claim trigger. OPEN ISSUE: requires cross-validation by reference-class-analyst against survival-only RWI deal subset. |by:m-and-a-deal-counsel |weight:MEDIUM
  |ctx: SRSA 2025 Deal Terms Study, slides 60-61. XVERIFY-LB2 AGREE (all percentages confirmed by GPT-5.4). Hypothesis is agent-inference pending reference-class-analyst validation.
DA-R2-EXIT-GATE: PASS | M&A deal terms review | 5 unresolved items: (1) RWI-proxy-vs-causal, (2) frequency≠achievability systematic conflation, (3) impossible-composite/no package framework, (4) RWI failure modes gap, (5) survival-conditional contamination in RWI stats | 2 untested consensus: RWI-is-transformative + 20-25th-pctl-heuristic | hygiene:pass | prompt-contamination:pass-with-caveats(H5,H6 missed) | XVERIFY:pass(6 runs, 3 agents) | engagement: loan-ops=A-, PS=B+, counsel=A, ref-class=A |by:devils-advocate |weight:primary(adversarial-gating)
  |ctx: private-target M&A deal terms analysis | SRSA 2025 study | R2 challenge round complete
H5:PM-role-relevance=PARTIALLY-CONFIRMED(K-shaped-bifurcation,¬elimination) |senior-PM-who-adapts=more-valuable |at-risk=mid-level-non-adapters |evidence:7300+-openings-3yr-high,Senior+-fastest-growing,AI-PM-$192K-$437K |XVERIFY:PARTIAL-unanimous(direction-confirmed,evidence-not-fully-proven) |by:product-strategist |weight:primary
  |ctx: review-12 PM 5yr strategy. H5 tests whether PM role is becoming irrelevant. Evidence from Lenny Rachitsky early 2026 data + multiple PM career sources. XVERIFY by gpt-5.4 + gemini-3.1-pro-preview both returned PARTIAL. K-shaped bifurcation directionally confirmed but evidence base not fully proven.
AI-wage-premium-magnitude: US avg ~25% (¬56%) | 56% figure = global outlier ¬US-specific baseline | premium window = 2-3yr before compression as skill diffuses | XVERIFY unanimous-partial confirms near-term premium real, persistence-to-2031 overstated | operative: early-skill-capture captures premium, late adopters face table-stakes requirement not premium |by:economics-analyst |weight:HIGH — XVERIFY-backed, two external models unanimous-partial
  |ctx: senior-PM-macro-strategy review 26.3.28 | PwC 2025 Global AI Jobs Barometer + cross-verification by openai-gpt5.4 + gemini-3.1-pro-preview
climate-economic-impacts-H3: CONFIRMED as material, present, and financially quantifiable | $1.47T RE value at risk from insurance trajectory | 5.2M climate migrants 2025 | +45% insurance since 2022 → +50% by 2030 | location = financial decision for knowledge workers with family obligations | climate-safe metros (Great Lakes, Midwest corridor, PNW) = compound advantage: lower cost + lower risk + emerging economic opportunity |by:economics-analyst |weight:HIGH — convergent multi-source T1 evidence, independent institutional sources
  |ctx: senior-PM-macro-strategy review 26.3.28 | H3 hypothesis test | sources: Consumer Fed of America, Axios/NBER, WEF, Fed Chair Powell Feb 2025, US Census 2025
H4-AI-acceleration=CONFIRMED-with-temporal-caveat: capability acceleration P=72%, but economic/career impact LAGS 3-5yr behind capability curve | S-curve compressed 20-30% vs prior GPTs (internet 15yr, mobile 13yr, cloud 12yr → AI ~10-12yr) | enterprise 72-88% surface adoption but 1% mature | capex sustainability questionable ($450B/$25B=5.6%, fiber analog) | IMPLICATION: 2026-2031 = middle of S-curve (max rate of change, not completion) |by:reference-class-analyst(r1) |weight:primary
  |ctx: 5yr PM career strategy review | H4 calibration via 5 reference classes + 2 XVERIFY (GPT-5.4=partial, Gemini=agree) | base rates from internet/mobile/cloud adoption timelines
H5-PM-role=TRANSFORMS-¬-ELIMINATED: P(transformed-viable)=72%, P(eliminated)=3%, P(diminished)=25% | base rate: tech transitions produce role TRANSFORMATION 75-85%, ELIMINATION <5%/5yr | financial analyst analog most relevant (judgment+coordination grew despite quant automation) | KEY: "PMs who use AI replace PMs who don't" — within-role displacement > cross-role | individual risk 25-35% IF fail to adapt = CAREER risk ¬ ROLE risk |by:reference-class-analyst(r1) |weight:primary
  |ctx: 5yr PM career strategy review | H5 calibration via 4 historical analogues (travel agents, secretaries, financial analysts, consultants-2008) + 2 XVERIFY (GPT-5.4=partial on precision, Gemini=agree) | BLS management occupation projections
H4-AI-acceleration: PARTIAL-CONFIRMED via mechanism-shift (test-time compute+agentic+open-source); pre-training scaling plateauing but capability gains in PM-relevant domains (code,analysis,synthesis) continue on 12-18mo cycles; "snowballing" directionally accurate ¬mechanistically precise; P(capability acceleration 2026-2031)=72% (reference-class-analyst); planning for plateau = miscalibrated downside for career strategy |by:tech-industry-analyst |weight:medium — XVERIFY partial, mechanism debate unresolved, PM-domain trajectory high-confidence
  |ctx: 5yr senior PM career strategy review | H4 hypothesis test | XVERIFY[openai:gpt-5.4]:partial | cross-verified with reference-class-analyst F1 | 26.3.28
H1 CONFIRMED: Geopolitical instability at near-record/decades-high levels (ACLED, SIPRI, GPI converge) and structural drivers (great-power competition, institutional erosion, climate-conflict nexus, economic fragmentation) ensure persistence through 2031. P(instability higher 2031 than 2026)=55-65%. Trajectory: sustained elevated with periodic acute spikes, NOT linear escalation to global war. XVERIFY:PARTIAL(GPT-5.4) — decades-high confirmed, exact count methodology-dependent. |by:geopolitical-strategist |weight:HIGH — primary domain expertise
  |ctx: 5-year PM career strategy review 26.3.28 — H1 hypothesis test on geopolitical instability persistence
thriving-vs-surviving-decision-science: thriving=proactive-resource-building(social-support,ACT-flexibility,purpose) BEFORE disruption requires it | surviving=reactive-restoration | SURVIVING-TRAP-for-PMs=defensive-specialization(loss-aversion+sunk-cost compound "prove I'm still valuable by doing what I'm known for") | evidence:APA-meta-g=0.50,MDPI-24-studies,Frontiers-RCT-2025 |by:cognitive-decision-scientist |weight:primary
  |ctx: 5yr PM career strategy review 26.3.28 | Q6: thriving vs surviving in high-uncertainty environments
H1/H2 framing recalibrated: evidence supports "elevated multi-theater risk + rearmament supercycle" ¬ "structural instability trend proven" | XVERIFY PARTIAL on both | career-relevant signals: defense-tech tailwind, geopolitical-compliance PM opportunity, geographic mobility optionality (family-constrained) |by:geopolitical-strategist |weight:domain-primary
  |ctx: 5yr PM career strategy review R1 26.3.28 — geopolitical analysis with XVERIFY calibration
econ:AI-PM-wage-premium-cyclical-not-structural — current 10-42% premium real but window ~2026-2029; normalizes as AI literacy becomes PM baseline (Mobile PM/Cloud PM analog). XVERIFY unanimous PARTIAL. Skill investment worthwhile NOW but premium compresses ~2029-2031. |by:economics-analyst |weight:primary
  |ctx: 5yr PM strategy review. H5 (PM role relevance) + H4 (AI acceleration). Falsification: H4 plateau extends window; H4 acceleration compresses window faster.
task-role disruption distinction is load-bearing for PM career strategy: task-layer disruption = genuine signal; role-layer obsolescence = availability-bias-amplified (with role-compression caveat from XVERIFY). HIGH-ROBUSTNESS strategy framing replaces "dominant strategy" — more precise and survives XVERIFY scrutiny. |by:cognitive-decision-scientist |weight:domain-primary(cognitive-decision-science,bias-detection,decision-architecture)
  |ctx: 5yr-PM-career-strategy R1 ANALYZE | H4+H5 bias testing | XVERIFY openai-PARTIAL+google-AGREE on task-role finding | XVERIFY openai-PARTIAL on dominant-strategy framing
H5 calibration: PM role P(transformed-viable)=72%, P(eliminated)=3%, P(diminished)=25% | financial-analyst reference class is primary analog (judgment-intensive, grew through automation) | within-role displacement (AI-using PMs vs non-AI PMs) is 5-10x larger risk than cross-role displacement (AI replaces PM function) | XVERIFY: GPT-5.4=partial(reference-classes-selective but directionally valid), Gemini=agree(high confidence) |by:reference-class-analyst |weight:primary
  |ctx: 5-year PM career strategy review — H5 hypothesis calibration using reference class forecasting
H4-AI-acceleration-calibrated: confirmed in specific domains (coding, writing, synthesis) at MEDIUM-HIGH confidence | near-AGI-within-5yr = LOW confidence | METR time horizon doubling real (131 days post-2023) but benchmark contamination (SWE-Verified 81% vs Pro 46%) and extrapolation uncertainty limit strong claims | for 5-yr PM strategy: plan for AI handling 60-80% of structured/templatable PM work by 2028-2030; senior judgment+trust+ambiguity remain high-value |by:tech-industry-analyst |weight:primary
  |ctx: XVERIFY(partial-both-models): gpt-5.4 says 7-month baseline broadly real, acceleration tentative; gemini raises source verification concerns | falsification: if SWE-bench Pro scores plateau at 45-50% through 2027, acceleration thesis weakens | PM wage premium is role-specific (builds AI products) not skill-upgrade (uses AI tools)
H5-verdict: PM role PARTIALLY CONFIRMED disrupted in current form — function NOT irrelevant, "execution-heavy generalist PM" form is at risk | K-shaped polarization directionally correct but domain-expert paths also viable (XVERIFY corrected binary framing) | senior PM in evolved form = high demand through 2031 | XVERIFY: cross_verify(gpt-5.4+gemini-3.1-pro, unanimous partial) on bifurcation claim |by:product-strategist |weight:primary
  |ctx: 5yr PM career strategy review, R1 round, product-strategist domain findings on Q1/Q2/Q3/H5. Based on PM job posting data (7,300+ global, Lenny's Newsletter), Agents Today K-shaped analysis, BLS management occupation growth projections.
AI systems fluency (eval design, behavior specification, feedback loop architecture) = highest-leverage skill investment for senior PM 2026-2031 | XVERIFY(agree, gpt-5.4, medium confidence) | companion requirement: domain depth + execution rigor + org influence | domain-agnostic AI fluency alone remains commoditizable |by:product-strategist |weight:primary
  |ctx: 5yr PM career strategy review, R1 round. Load-bearing finding for Q2 (evolved role skills) and F[PS-6] career positioning recommendations. XVERIFY run on openai gpt-5.4.
AUDIT-VERDICT[26.3.29|sigma-ui-build]: YELLOW |§7=followed |§2d=clean(PD-untagged-20%) |§2=substantive |DA=adequate(no-exit-gate-in-workspace) |§6=clean |CB=not-needed |§4a-§4d=partial(§4b-checked,§4a/§4d-not-formal) |5-flagged-findings |remediation:DA-exit-gate+BELIEF-scores+PD-tags+TA-DB-blocks |no-rerun-needed |by:sigma-audit |weight:process-verification
  |ctx: sigma-ui Phase A BUILD (5+DA, TIER-2, 26.3.28-29)

26.3.30|asyncio-primitives-bound-to-creating-loop: asyncio.Semaphore (and Lock, Event, Condition) created in one event loop CANNOT be acquired/waited in a different loop. asyncio.run() in a worker thread creates a new event loop — any Semaphore from the main thread raises RuntimeError. Fix: create asyncio primitives INSIDE the coroutine that uses them, or use threading.Semaphore for cross-thread caps. For ThreadPoolExecutor + asyncio.run() pattern: create fresh object (including any containing class) inside the thread. |evidence: DA[#7] + IE independent discovery in B3 |Python 3.10+ behavior |by:implementation-engineer,devils-advocate |weight:primary
  |ctx: sigma-ui B3 build, threading + asyncio integration. Source: [independent-research] T1.

## ollama-mcp-bridge F1 BUILD audit (26.4.8)

AUDIT-VERDICT:YELLOW |by:sigma-audit(independent) |weight:primary
  |ctx: BUILD: ollama-mcp-bridge F1 upgrade. 5 agents (TA,SS,IE,CQA,DA). TIER-2. Q1-Q6 scope, Q2 deferred.
  |findings: (1) BELIEF[] absent (3rd consecutive build), (2) build-track source tags missing (IE+CQA), (3) §6 CONTAMINATION-CHECK absent, (4) XVERIFY skipped (13 providers avail)
  |strengths: DA substantive (9 challenges, genuine scope change on Q[2]), §4a-d all exercised, security-specialist exemplary provenance, BUILD guardrails PASS
  |DA-plan-exit-gate: PASS B+ (3.2/4.0) |DA-build-exit-gate: PASS A- (3.6/4.0)
  |remediation: targeted fixes, no rerun needed
  |status: open — remediation items pending

AUDIT-FLAG[26.4.8]: BELIEF[]-systematic-absence |3/3-audited-builds-missing |remediation:lead-must-write-BELIEF[]s-retroactively+going-forward |status:open
AUDIT-FLAG[26.4.8]: DA-§2d-audit-scope-incomplete |only-audited-plan-track-agents |remediation:DA-audit-must-cover-all-agents |status:open
loan-admin-KB-robustness: STRONG-overall|factual-accuracy-HIGH|prior-implementation(26.3.13)-confirmed-thorough|3-actionable-updates: (1)CME-Term-SOFR-distribution-fee-waiver-expired-Apr-1-2026→update-Doc3-§1-CRITICAL, (2)add-explicit-payment-waterfall-ordered-list-to-Doc3-§12-or-Doc6-§1.1, (3)add-Oct-2025-LMA/LSTA/APLMA-Transition-Loan-Guide-to-Doc2-§1 |analysis-bundle-H2: CONFIRMED-valid-8wk-later |by:loan-ops-tech-specialist |weight:primary
  |ctx: Loan admin KB + analysis bundle robustness review, Apr 9 2026, LOT specialist r1 findings
CRD6 loan-agency/trustee exemption from core-banking licensing: MAINTAIN MEDIUM-HIGH confidence. 5-law-firm consensus intact (Mayer Brown, DLA Piper, Norton Rose, Hogan Lovells, BCLP). XVERIFY-PARTIAL from OpenAI (medium confidence, fact-specific). Key risk: France banking monopoly may be broader; agent role with discretion could face closer scrutiny. Practical guidance: grandfathering (pre-Jul 11, 2026 contracts) is reliable mitigation; post-Jul 2026 EU mandates require firm-specific legal analysis before acceptance. |by:regulatory-licensing-specialist |weight:HIGH — domain expertise + external verification
  |ctx: Loan admin KB refresh review 26.4.09. CRD6 Article 21c effective Jan 11, 2027.
calibration:bundle-estimates-optimistic-30-50% |breakeven:30-48mo→42-60mo |capital:$23-37M→$30-55M |ramp:140-facilities→60-90-by-mo48 |margin:70%→50-60% |reference-class-adjusted |XVERIFY:2×PARTIAL |by:reference-class-analyst |weight:primary
  |ctx: loan-admin-KB-robustness-review-r1 | 5 reference classes, 5 analogues, 8 calibrated estimates, 5 pre-mortems applied
BDC-capital-formation-bear-case-is-now-operative-base-case(26.4.9) |greenfield-mandates=10-15%(¬40%-base,¬15-20%-bear) |restructuring/workout=25-35%-near-term-pipeline |fundraising-narrative="countercyclical-infrastructure"=REQUIRED-base-case-not-bear-case-option |by:product-strategist |weight:primary
  |ctx: BDC nontraded sales -49% from peak; RA Stanger -40% YoY forecast; Fitch PCDR 5.8%/9.2% privately monitored; tariff/macro stress Q1 2026; several flagship BDC funds hit redemption limits. March bear case was correctly calibrated to these figures as projections — they are now confirmed actuals.
S&P-DataXchange-AmendX-confirmed-infrastructure-not-competitor(26.4.9) |"integrate-as-partner"=VALIDATED |TIA-§310+trust-law-prevents-S&P-assuming-fiduciary-duties-without-charter |charter-gated-competitive-window=12-18mo-UNCHANGED |by:product-strategist |weight:primary
  |ctx: DataXchange+AmendX launched March 3 2026. Press release explicitly positions as "platform for agents to deliver notices to lenders." XVERIFY[openai:gpt-5.4] PARTIAL confirmed window not compressed. March analysis "integrate as infrastructure partner" recommendation validated.
AUDIT-FLAG[26.4.13]: B7 sigma-predict RED — DA never spawned, entire adversarial layer bypassed. Build output (130 tests, 0 regressions) accepted without remediation. Process fix: 3-conversation split + default-deny code writes. |remediation:structural(shipped) |status:closed |by:sigma-audit |weight:primary
  |ctx: B7 build produced competent code but zero adversarial challenge. Accepted as-is, structural fix shipped same session.
sigma-chatroom M1a+M1b BUILD: purpose-built providers/ module (¬import sigma-verify clients.py), native per-SDK tool-use (¬ollama-mcp-bridge), tool-exec loop in TurnEngine (¬Provider), IC[2] dual additions (final_message + kind=tool_result), 3-tier merge-gate test strategy (hand-golden outbound + inbound + round-trip), 60% context budget + len//4 estimate, raw event capture default-on when tool_use_reliability != "reliable", research-question=memory-invocation-coherence, rendering-option deferred to pre-M2 STEP-1, Streamlit-vs-Textual-TUI decided at pre-M2 STEP-3b via 2h comparison sketch, devstral→deepseek escalation manual-M1b auto-M1c+. Plan locked C1 2026-04-21 at P=0.87 post-R2. |by:tech-architect+ui-ux-engineer+lead-user-decisions |weight:primary
  |ctx: sigma-chatroom-m1ab C1 PLAN phase, 2026-04-20 to 2026-04-21, TIER-2 BUILD, 5 agents (tech-architect, ui-ux-engineer, implementation-engineer, code-quality-analyst, devils-advocate) plus lead. DA-r2 exit-gate PASS engagement A- rounds 2/5 budget preserved. XVERIFY documented gap per §2h. BELIEF[P(plan-ready)] 0.82→0.87.

→ actions:
→ new team decision → format: topic:decision |by:expert |weight:primary/advisory
→ disagreement → record both positions with |ctx from each agent
→ revisiting old decision → check if conditions changed, note in ctx
